-
1
-
-
2642709177
-
Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators
-
Palella FJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998;338(13):853-860
-
(1998)
N Engl J Med
, vol.338
, Issue.13
, pp. 853-860
-
-
Palella, F.J.1
Delaney, K.M.2
Moorman, A.C.3
-
2
-
-
0038162585
-
EuroSIDA study group. Decline in the AIDS and death rates in the EuroSIDA study: An observational study
-
Mocroft A, Ledergerber B, Katlama C, et al; EuroSIDA study group. Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet. 2003;362(9377):22-29
-
(2003)
Lancet
, vol.362
, Issue.9377
, pp. 22-29
-
-
Mocroft, A.1
Ledergerber, B.2
Katlama, C.3
-
3
-
-
34147184752
-
Continued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapy
-
Lima VD, Hogg RS, Harrigan PR, et al. Continued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapy. AIDS. 2007;21(6):685-692
-
(2007)
AIDS
, vol.21
, Issue.6
, pp. 685-692
-
-
Lima, V.D.1
Hogg, R.S.2
Harrigan, P.R.3
-
4
-
-
84901454172
-
IPEC/FIOCRUZ Cohort and the Aquitaine ANRS C03 Study Group. AIDS and non-AIDS severe morbidity associated with hospitalizations among HIV-infected patients in two regions with universal access to care and antiretroviral therapy, France and Brazil, 2000-2008: Hospital-based cohort studies
-
Luz PM, Bruyand M, Ribeiro S, et al; IPEC/FIOCRUZ Cohort and the Aquitaine ANRS C03 Study Group. AIDS and non-AIDS severe morbidity associated with hospitalizations among HIV-infected patients in two regions with universal access to care and antiretroviral therapy, France and Brazil, 2000-2008: hospital-based cohort studies. BMC Infect Dis. 2014;14:278
-
(2014)
BMC Infect Dis
, vol.14
, pp. 278
-
-
Luz, P.M.1
Bruyand, M.2
Ribeiro, S.3
-
5
-
-
33748116898
-
HIV Outpatient Study Investigators. Mortality in the highly active antiretroviral therapy era: Changing causes of death and disease in the HIV outpatient study
-
Palella FJ Jr, Baker RK, Moorman AC, et al; HIV Outpatient Study Investigators. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr. 2006;43(1):27-34
-
(2006)
J Acquir Immune Defic Syndr
, vol.43
, Issue.1
, pp. 27-34
-
-
Palella, F.J.1
Baker, R.K.2
Moorman, A.C.3
-
6
-
-
33645277852
-
Triservice AIDS Clinical Consortium. Comparisons of causes of death and mortality rates among HIV-infected persons: Analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras
-
Crum NF, Riffenburgh RH, Wegner S, et al; Triservice AIDS Clinical Consortium. Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras. J Acquir Immune Defic Syndr. 2006;41(2):194-200
-
(2006)
J Acquir Immune Defic Syndr
, vol.41
, Issue.2
, pp. 194-200
-
-
Crum, N.F.1
Riffenburgh, R.H.2
Wegner, S.3
-
7
-
-
84927566259
-
ANRS EN20 Mortalite 2010 Study Group. Causes of death among HIV-infected patients in France in 2010 (national survey): Trends since 2000
-
Morlat P, Roussillon C, Henard S, et al; ANRS EN20 Mortalite 2010 Study Group. Causes of death among HIV-infected patients in France in 2010 (national survey): trends since 2000. AIDS. 2014;28(8): 1181-1191
-
(2014)
AIDS
, vol.28
, Issue.8
, pp. 1181-1191
-
-
Morlat, P.1
Roussillon, C.2
Henard, S.3
-
8
-
-
68049131269
-
Trends in mortality and causes of death among women with HIV in the United States: A 10-year study
-
French AL, Gawel SH, Hershow R, et al. Trends in mortality and causes of death among women with HIV in the United States: a 10-year study. J Acquir Immune Defic Syndr. 2009;51(4):399-W6
-
(2009)
J Acquir Immune Defic Syndr
, vol.4
, Issue.51
, pp. 36-399
-
-
French, A.L.1
Gawel, S.H.2
Hershow, R.3
-
9
-
-
77957305505
-
EuroSIDA Study Group. Serious fatal and nonfatal non-AIDS-defining illnesses in Europe
-
Mocroft A, Reiss P, Gasiorowski J, et al; EuroSIDA Study Group. Serious fatal and nonfatal non-AIDS-defining illnesses in Europe. J Acquir Immune Defic Syndr. 2010;55(2):262-270
-
(2010)
J Acquir Immune Defic Syndr
, vol.55
, Issue.2
, pp. 262-270
-
-
Mocroft, A.1
Reiss, P.2
Gasiorowski, J.3
-
10
-
-
84859743542
-
Trends in reasons for hospitalization in a multisite United States cohort of persons living with HIV, 2001-2008
-
Berry SA, Fleishman JA, Moore RD, Gebo KA; HIV ResearchNetwork. Trends in reasons for hospitalization in a multisite United States cohort of persons living with HIV, 2001-2008. J Acquir Immune Defic Syndr. 2012;59(4):368-375
-
(2012)
J Acquir Immune Defic Syndr
, vol.59
, Issue.4
, pp. 368-375
-
-
Berry, S.A.1
Fleishman, J.A.2
Moore, R.D.3
Gebo, K.A.4
Researchnetwork, H.I.V.5
-
11
-
-
75649121819
-
Inpatient admissions and outpatient visits in persons with and without HIV infection in Denmark, 1995-2007
-
Engsig FN, Hansen AB, Gerstoft J, Kronborg G, Larsen CS, Obel N. Inpatient admissions and outpatient visits in persons with and without HIV infection in Denmark, 1995-2007. AIDS. 2010;24(3):457-461
-
(2010)
AIDS
, vol.24
, Issue.3
, pp. 457-461
-
-
Engsig, F.N.1
Hansen, A.B.2
Gerstoft, J.3
Kronborg, G.4
Larsen, C.S.5
Obel, N.6
-
12
-
-
47649129312
-
Working Group 2. Epidemiological evidence for cardiovascular disease in HIV-infected patients and relationship to highly active antiretroviral therapy
-
Currier JS, Lundgren JD, Carr A, et al; Working Group 2. Epidemiological evidence for cardiovascular disease in HIV-infected patients and relationship to highly active antiretroviral therapy. Circulation. 2008;118(2):29-35
-
(2008)
Circulation
, vol.118
, Issue.2
, pp. 29-35
-
-
Currier, J.S.1
Lundgren, J.D.2
Carr, A.3
-
13
-
-
34250671221
-
Increased acute myo-cardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease
-
Triant VA, Lee H, Hadigan C, Grinspoon SK. Increased acute myo-cardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrinol Metab. 2007;92(7):2506-2512
-
(2007)
J Clin Endocrinol Metab
, vol.92
, Issue.7
, pp. 2506-2512
-
-
Triant, V.A.1
Lee, H.2
Hadigan, C.3
Grinspoon, S.K.4
-
14
-
-
84864307980
-
Relative risk of cardiovascular disease among people living with HIV: A systematic review and meta-analysis
-
Islam FM, Wu J, Jansson J, Wilson DP. Relative risk of cardiovascular disease among people living with HIV: a systematic review and meta-analysis. HIV Med. 2012;13(8):453-t68
-
(2012)
HIV Med
, vol.13
, Issue.8
, pp. 68-456
-
-
Islam, F.M.1
Wu, J.2
Jansson, J.3
Wilson, D.P.4
-
16
-
-
50249108415
-
Peripheral arterial disease in HIV patients older than 50 years of age
-
Palacios R, Alonso I, Hidalgo A, et al. Peripheral arterial disease in HIV patients older than 50 years of age. AIDS Res Hum Retroviruses. 2008;24(8):1043-1046
-
(2008)
AIDS Res Hum Retroviruses
, vol.24
, Issue.8
, pp. 1043-1046
-
-
Palacios, R.1
Alonso, I.2
Hidalgo, A.3
-
17
-
-
38349193415
-
Both long-term HIV infection and highly active antiretroviral therapy are independent risk factors for early carotid atherosclerosis
-
Lorenz MW, Stephan C, Harmjanz A, et al. Both long-term HIV infection and highly active antiretroviral therapy are independent risk factors for early carotid atherosclerosis. Atherosclerosis. 2008;196(2): 720-726
-
(2008)
Atherosclerosis
, vol.196
, Issue.2
, pp. 720-726
-
-
Lorenz, M.W.1
Stephan, C.2
Harmjanz, A.3
-
18
-
-
52249123479
-
Subclinical coronary atherosclerosis, HIV infection and antiretroviral therapy: Multicenter AIDS Cohort Study
-
Kingsley LA, Cuervo-Rojas J, Munoz A, et al. Subclinical coronary atherosclerosis, HIV infection and antiretroviral therapy: Multicenter AIDS Cohort Study. AIDS. 2008;22(13):1589-1599
-
(2008)
AIDS
, vol.22
, Issue.13
, pp. 1589-1599
-
-
Kingsley, L.A.1
Cuervo-Rojas, J.2
Munoz, A.3
-
19
-
-
39749147713
-
Swiss HIV Cohort Study. High prevalence of peripheral arterial disease in HIV-infected persons
-
Periard D, Cavassini M, Taffe P, et al; Swiss HIV Cohort Study. High prevalence of peripheral arterial disease in HIV-infected persons. Clin Infect Dis. 2008;46(5):761-767
-
(2008)
Clin Infect Dis
, vol.46
, Issue.5
, pp. 761-767
-
-
Periard, D.1
Cavassini, M.2
Taffe, P.3
-
20
-
-
37549015969
-
SMART Study Investigators. Asymptomatic myocardial ischaemia in HIV-infected adults
-
Carr A, Grund B, Neuhaus J, et al; SMART Study Investigators. Asymptomatic myocardial ischaemia in HIV-infected adults. AIDS. 2008;22(2):257-267
-
(2008)
AIDS
, vol.22
, Issue.2
, pp. 257-267
-
-
Carr, A.1
Grund, B.2
Neuhaus, J.3
-
21
-
-
33646094737
-
Endothelial function in HIV-infected persons
-
Solages A, Vita JA, Thornton DJ, et al. Endothelial function in HIV-infected persons. Clin Infect Dis. 2006;42(9):1325-1332
-
(2006)
Clin Infect Dis
, vol.42
, Issue.9
, pp. 1325-1332
-
-
Solages, A.1
Vita, J.A.2
Thornton, D.J.3
-
22
-
-
84855899694
-
Recent developments regarding human immunodeficiency virus infection and stroke
-
Sen S, Rabinstein AA, Elkind MS, Powers WJ. Recent developments regarding human immunodeficiency virus infection and stroke. Cerebrovasc Dis. 2012;33(3):209-218
-
(2012)
Cerebrovasc Dis
, vol.33
, Issue.3
, pp. 209-218
-
-
Sen, S.1
Rabinstein, A.A.2
Elkind, M.S.3
Powers, W.J.4
-
23
-
-
79951483390
-
Increasing incidence of ischemic stroke in patients with HIV infection
-
Ovbiagele B, Nath A. Increasing incidence of ischemic stroke in patients with HIV infection. Neurology. 2011;76(5):444-t50
-
(2011)
Neurology
, vol.76
, Issue.5
, pp. 50-444
-
-
Ovbiagele, B.1
Nath, A.2
-
24
-
-
0028070795
-
Frequency of development of acute global left ventricular dysfunction in human immunodeficiency virus infection
-
De Castro S, d'Amati G, Gallo P, et al. Frequency of development of acute global left ventricular dysfunction in human immunodeficiency virus infection. J Am Coll Cardiol. 1994;24(4):1018-1024
-
(1994)
J Am Coll Cardiol
, vol.24
, Issue.4
, pp. 1018-1024
-
-
De Castro, S.1
D'amati, G.2
Gallo, P.3
-
25
-
-
84882926342
-
Comprehensive cardiac magnetic resonance imaging and spectroscopy reveal a high burden of myocardial disease in HIV patients
-
Holloway CJ, Ntusi N, Suttie J, et al. Comprehensive cardiac magnetic resonance imaging and spectroscopy reveal a high burden of myocardial disease in HIV patients. Circulation. 2013;128(8):814-822
-
(2013)
Circulation
, vol.128
, Issue.8
, pp. 814-822
-
-
Holloway, C.J.1
Ntusi, N.2
Suttie, J.3
-
26
-
-
84886094008
-
Risk of QTc prolongation in a cohort of opioid-dependent HIV-infected patients on methadone maintenance therapy
-
Vallecillo G, Mojal S, Roquer A, et al. Risk of QTc prolongation in a cohort of opioid-dependent HIV-infected patients on methadone maintenance therapy. Clin Infect Dis. 2013;57(8):1189-1194
-
(2013)
Clin Infect Dis
, vol.57
, Issue.8
, pp. 1189-1194
-
-
Vallecillo, G.1
Mojal, S.2
Roquer, A.3
-
27
-
-
84896038060
-
Effect of left ventricular dysfunction and viral load on risk of sudden cardiac death in patients with human immunodeficiency virus
-
Moyers BS, Secemsky EA, Vittinghoff E, et al. Effect of left ventricular dysfunction and viral load on risk of sudden cardiac death in patients with human immunodeficiency virus. Am J Cardiol. 2014;113(7):1260-1265
-
(2014)
Am J Cardiol
, vol.113
, Issue.7
, pp. 1260-1265
-
-
Moyers, B.S.1
Secemsky, E.A.2
Vittinghoff, E.3
-
28
-
-
80755136930
-
Swiss HIV Cohort Study. Morbidity and aging in HIV-infected persons: The Swiss HIV cohort study
-
Hasse B, Ledergerber B, Furrer H, et al; Swiss HIV Cohort Study. Morbidity and aging in HIV-infected persons: the Swiss HIV cohort study. Clin Infect Dis. 2011;53(11):1130-1139
-
(2011)
Clin Infect Dis
, vol.53
, Issue.11
, pp. 1130-1139
-
-
Hasse, B.1
Ledergerber, B.2
Furrer, H.3
-
29
-
-
61849131811
-
HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity
-
Deeks SG, Phillips AN. HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity. BMJ. 2009;338:a3172
-
(2009)
BMJ
, vol.a3172
, pp. 338
-
-
Deeks, S.G.1
Phillips, A.N.2
-
30
-
-
79551614790
-
HIV infection, inflammation, immunosenescence, and aging
-
Deeks SG. HIV infection, inflammation, immunosenescence, and aging. Annu Rev Med. 2011;62:141-155
-
(2011)
Annu Rev Med
, vol.62
, pp. 141-155
-
-
Deeks, S.G.1
-
31
-
-
48749099532
-
Aging and infectious diseases: Workshop on HIV infection and aging: What is known and future research directions
-
Effros RB, Fletcher CV, Gebo K, et al. Aging and infectious diseases: workshop on HIV infection and aging: what is known and future research directions. Clin Infect Dis. 2008;47(4):542-553
-
(2008)
Clin Infect Dis
, vol.47
, Issue.4
, pp. 542-553
-
-
Effros, R.B.1
Fletcher, C.V.2
Gebo, K.3
-
32
-
-
80755123417
-
Premature age-related comorbidi-ties among HIV-infected persons compared with the general population
-
Guaraldi G, Orlando G, Zona S, et al. Premature age-related comorbidi-ties among HIV-infected persons compared with the general population. Clin Infect Dis. 2011;53(11):1120-1126
-
(2011)
Clin Infect Dis
, vol.53
, Issue.11
, pp. 1120-1126
-
-
Guaraldi, G.1
Orlando, G.2
Zona, S.3
-
33
-
-
70350457524
-
Human immunodeficiency virus in an aging population, a complication of success
-
Kirk JB, Goetz MB. Human immunodeficiency virus in an aging population, a complication of success. J Am GeriatrSoc. 2009;57(11): 2129-2138
-
(2009)
J Am GeriatrSoc
, vol.57
, Issue.11
, pp. 2129-2138
-
-
Kirk, J.B.1
Goetz, M.B.2
-
34
-
-
61849131811
-
HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity
-
Deeks SG, Phillips AN. HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity. BMJ. 2009;338:31-72
-
(2009)
BMJ
, vol.338
, pp. 31-72
-
-
Deeks, S.G.1
Phillips, A.N.2
-
35
-
-
40449103813
-
Aging and infectious diseases: Do patterns of comorbidity vary by HIV status, age, and HIV severity?
-
Goulet JL, Fultz SL, Rimland D, et al. Aging and infectious diseases: do patterns of comorbidity vary by HIV status, age, and HIV severity? Clin Infect Dis. 2007;45(12):1593-1601
-
(2007)
Clin Infect Dis
, vol.45
, Issue.12
, pp. 1593-1601
-
-
Goulet, J.L.1
Fultz, S.L.2
Rimland, D.3
-
36
-
-
17144463863
-
Severe premature coronary artery disease with protease inhibitors
-
Henry K, Melroe H, Huebsch J, et al. Severe premature coronary artery disease with protease inhibitors. Lancet. 1998;351(9112):13-28
-
(1998)
Lancet
, vol.351
, Issue.9112
, pp. 13-28
-
-
Henry, K.1
Melroe, H.2
Huebsch, J.3
-
37
-
-
0032572211
-
Vascular complications associated with use of HIV protease inhibitors
-
Gallet B, Pulik M, Genet P, Chedin P, Hiltgen M. Vascular complications associated with use of HIV protease inhibitors. Lancet. 1998; 351(9120):1958-1959
-
(1998)
Lancet
, vol.351
, Issue.9120
, pp. 1958-1959
-
-
Gallet, B.1
Pulik, M.2
Genet, P.3
Chedin, P.4
Hiltgen, M.5
-
38
-
-
0345064200
-
Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group. Combination antiret-roviral therapy and the risk of myocardial infarction
-
Friis-M0ller N, Sabin CA, Weber R, et al; Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group. Combination antiret-roviral therapy and the risk of myocardial infarction. N Engl J Med. 2003;349(21):1993-2003
-
(2003)
N Engl J Med
, vol.349
, Issue.21
, pp. 1993-2003
-
-
Friis-Moller, N.1
Sabin, C.A.2
Weber, R.3
-
39
-
-
0035134609
-
Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy
-
Hadigan C, Meigs JB, Corcoran C, et al. Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy. Clin Infect Dis. 2001;32(1):130-139
-
(2001)
Clin Infect Dis
, vol.32
, Issue.1
, pp. 130-139
-
-
Hadigan, C.1
Meigs, J.B.2
Corcoran, C.3
-
40
-
-
84902001402
-
HIV infection and cardiovascular disease
-
Hemkens LG, Bucher HC. HIV infection and cardiovascular disease. Eur Heart J. 2014;35(21):1373-1381
-
(2014)
Eur Heart J
, vol.35
, Issue.21
, pp. 1373-1381
-
-
Hemkens, L.G.1
Bucher, H.C.2
-
41
-
-
84857829318
-
Dietary intervention prevents dyslipidemia associated with highly active antiretroviral therapy in human immunodeficiency virus type 1 -infected individuals: A randomized trial
-
Lazzaretti RK, Kuhmmer R, Sprinz E, Polanczyk CA, Ribeiro JP. Dietary intervention prevents dyslipidemia associated with highly active antiretroviral therapy in human immunodeficiency virus type 1 -infected individuals: a randomized trial. J Am Coll Cardiol. 2012;59(11): 979-988
-
(2012)
J Am Coll Cardiol
, vol.59
, Issue.11
, pp. 979-988
-
-
Lazzaretti, R.K.1
Kuhmmer, R.2
Sprinz, E.3
Polanczyk, C.A.4
Ribeiro, J.P.5
-
42
-
-
76749138252
-
HIV protease inhibitor ritonavir induces endothelial dysfunction in porcine arteries
-
Conklin B, Fu W, Lin P, Lundsen A, Yao Q, Chen C. HIV protease inhibitor ritonavir induces endothelial dysfunction in porcine arteries. J Surg Res. 2003;114:249
-
(2003)
J Surg Res
, vol.114
, pp. 249
-
-
Conklin, B.1
Fu, W.2
Lin, P.3
Lundsen, A.4
Yao, Q.5
Chen, C.6
-
43
-
-
27744590942
-
Indinavir impairs endothelial function in healthy HIV-negative men
-
Shankar SS, Dube MP, Gorski JC, Klaunig JE, Steinberg HO. Indinavir impairs endothelial function in healthy HIV-negative men. Am Heart J. 2005;150(5):933
-
(2005)
Am Heart J
, vol.150
, Issue.5
, pp. 933
-
-
Shankar, S.S.1
Dube, M.P.2
Gorski, J.C.3
Klaunig, J.E.4
Steinberg, H.O.5
-
44
-
-
34447289419
-
Some HIV antiretrovirals increase oxidative stress and alter chemokine, cytokine or adiponectin production in human adipocytes and macrophages
-
Lagathu C, Eustace B, Prot M, et al. Some HIV antiretrovirals increase oxidative stress and alter chemokine, cytokine or adiponectin production in human adipocytes and macrophages. Antivir Ther. 2007;12(4): 489-500
-
(2007)
Antivir Ther
, vol.12
, Issue.4
, pp. 489-500
-
-
Lagathu, C.1
Eustace, B.2
Prot, M.3
-
45
-
-
78650414373
-
Premature senescence of vascular cells is induced by HIV protease inhibitors: Implication of prelamin A and reversion by statin
-
Lefevre C, Auclair M, Boccara F, et al. Premature senescence of vascular cells is induced by HIV protease inhibitors: implication of prelamin A and reversion by statin. Arterioscler Thromb Vasc Biol. 2010;30(12): 2611-2620
-
(2010)
Arterioscler Thromb Vasc Biol
, vol.30
, Issue.12
, pp. 2611-2620
-
-
Lefevre, C.1
Auclair, M.2
Boccara, F.3
-
46
-
-
33751515147
-
Strategies for Management of Antiretroviral Therapy (SMART) Study Group. CD4+ count-guided interruption of antiretroviral treatment
-
El-Sadr WM, Lundgren J, Neaton JD, et al; Strategies for Management of Antiretroviral Therapy (SMART) Study Group. CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med. 2006;355(22): 2283-2296
-
(2006)
N Engl J Med
, vol.355
, Issue.22
, pp. 2283-2296
-
-
El-Sadr, W.M.1
Lundgren, J.2
Neaton, J.D.3
-
47
-
-
30944431733
-
Impact of HIV and highly active antiretroviral therapy on leukocyte adhesion molecules, arterial inflammation, dyslipidemia, and atherosclerosis
-
Fisher SD, Miller TL, Lipshultz SE. Impact of HIV and highly active antiretroviral therapy on leukocyte adhesion molecules, arterial inflammation, dyslipidemia, and atherosclerosis. Atherosclerosis. 2006; 185(1):1-11
-
(2006)
Atherosclerosis
, vol.185
, Issue.1
, pp. 1-11
-
-
Fisher, S.D.1
Miller, T.L.2
Lipshultz, S.E.3
-
48
-
-
33947644079
-
Current update on HIV-associated vascular disease and endothelial dysfunction
-
Mu H, Chai H, Lin PH, Yao Q, Chen C. Current update on HIV-associated vascular disease and endothelial dysfunction. World J Surg. 2007;31(4):632-643
-
(2007)
World J Surg
, vol.31
, Issue.4
, pp. 632-643
-
-
Mu, H.1
Chai, H.2
Lin, P.H.3
Yao, Q.4
Chen, C.5
-
49
-
-
42049101411
-
Human immunodeficiency virus (HIV) infects human arterial smooth muscle cells in vivo and in vitro: Implications for the pathogenesis of HIV-mediated vascular disease
-
Eugenin EA, Morgello S, Klotman ME, et al. Human immunodeficiency virus (HIV) infects human arterial smooth muscle cells in vivo and in vitro: implications for the pathogenesis of HIV-mediated vascular disease. Am J Pathol. 2008;172(4):1100-1111
-
(2008)
Am J Pathol
, vol.172
, Issue.4
, pp. 1100-1111
-
-
Eugenin, E.A.1
Morgello, S.2
Klotman, M.E.3
-
50
-
-
0034034925
-
HIV-1 Tat increases endothelial solute permeability through tyrosine kinase and mitogen-activated protein kinase-dependent pathways
-
Oshima T, Flores SC, Vaitaitis G, et al. HIV-1 Tat increases endothelial solute permeability through tyrosine kinase and mitogen-activated protein kinase-dependent pathways. AIDS. 2000;14(5):475-482
-
(2000)
AIDS
, vol.14
, Issue.5
, pp. 475-482
-
-
Oshima, T.1
Flores, S.C.2
Vaitaitis, G.3
-
51
-
-
0034805390
-
Cysteine-rich and basic domain HIV-1 Tat peptides inhibit angiogenesis and induce endothelial cell apoptosis
-
Jia H, Lohr M, Jezequel S, et al. Cysteine-rich and basic domain HIV-1 Tat peptides inhibit angiogenesis and induce endothelial cell apoptosis. Biochem Biophys Res Commun. 2001;283(2):469-479
-
(2001)
Biochem Biophys Res Commun
, vol.283
, Issue.2
, pp. 469-479
-
-
Jia, H.1
Lohr, M.2
Jezequel, S.3
-
52
-
-
0035394317
-
Apoptotic effects in primary human umbilical vein endothelial cell cultures caused by exposure to virion-associated and cell membrane-associated HIV-1 gp120
-
Huang MB, Khan M, Garcia-Barrio M, Powell M, Bond VC. Apoptotic effects in primary human umbilical vein endothelial cell cultures caused by exposure to virion-associated and cell membrane-associated HIV-1 gp120. J Acquir Immune Defic Syndr. 2001;27(3):213-221
-
(2001)
J Acquir Immune Defic Syndr
, vol.27
, Issue.3
, pp. 213-221
-
-
Huang, M.B.1
Khan, M.2
Garcia-Barrio, M.3
Powell, M.4
Bond, V.C.5
-
53
-
-
0030860877
-
Human immunodeficiency virus-1-tat protein induces the cell surface expression of endothelial leukocyte adhesion molecule-1, vascular cell adhesion molecule-1, and intercellular adhesion molecule-1 in human endothelial cells
-
Dhawan S, Puri RK, Kumar A, Duplan H, Masson JM, Aggarwal BB. Human immunodeficiency virus-1-tat protein induces the cell surface expression of endothelial leukocyte adhesion molecule-1, vascular cell adhesion molecule-1, and intercellular adhesion molecule-1 in human endothelial cells. Blood. 1997;90(4):1535-1544
-
(1997)
Blood
, vol.90
, Issue.4
, pp. 1535-1544
-
-
Dhawan, S.1
Puri, R.K.2
Kumar, A.3
Duplan, H.4
Masson, J.M.5
Aggarwal, B.B.6
-
54
-
-
0036131112
-
HIV-1 envelope glycoprotein 120 increases intercellular adhesion molecule-1 expression by human endothelial cells
-
Ren Z, Yao Q, Chen C. HIV-1 envelope glycoprotein 120 increases intercellular adhesion molecule-1 expression by human endothelial cells. Lab Invest. 2002;82(3):245-255
-
(2002)
Lab Invest
, vol.82
, Issue.3
, pp. 245-255
-
-
Ren, Z.1
Yao, Q.2
Chen, C.3
-
55
-
-
84892372311
-
Can early therapy reduce inflammation?
-
Sandler NG, Sereti I. Can early therapy reduce inflammation? Curr Opin HIV AIDS. 2014;9(1):72-79
-
(2014)
Curr Opin HIV AIDS
, vol.9
, Issue.1
, pp. 72-79
-
-
Sandler, N.G.1
Sereti, I.2
-
56
-
-
84866978487
-
Acute plasma biomarkers of T cell activation set-point levels and of disease progression in HIV-1 infection
-
Liovat AS, Rey-Cuille MA, Lecuroux C, et al. Acute plasma biomarkers of T cell activation set-point levels and of disease progression in HIV-1 infection. PLoS One. 2012;7(10):e46143
-
(2012)
PLoS One
, vol.7
, Issue.10
, pp. e46143
-
-
Liovat, A.S.1
Rey-Cuille, M.A.2
Lecuroux, C.3
-
57
-
-
77954076151
-
Increased monocyte turnover from bone marrow correlates with severity of SIV encephalitis and CD163 levels in plasma
-
Burdo TH, Soulas C, Orzechowski K, et al. Increased monocyte turnover from bone marrow correlates with severity of SIV encephalitis and CD163 levels in plasma. PLoSPathog. 2010;6(4):1000842
-
(2010)
PLoSPathog
, vol.6
, Issue.4
, pp. 1000842
-
-
Burdo, T.H.1
Soulas, C.2
Orzechowski, K.3
-
58
-
-
84859938086
-
HIV infection induces age-related changes to monocytes and innate immune activation in young men that persist despite combination antiretroviral therapy
-
Hearps AC, Maisa A, Cheng WJ, et al. HIV infection induces age-related changes to monocytes and innate immune activation in young men that persist despite combination antiretroviral therapy. AIDS. 2012;26(7): 843-853
-
(2012)
AIDS
, vol.26
, Issue.7
, pp. 843-853
-
-
Hearps, A.C.1
Maisa, A.2
Cheng, W.J.3
-
59
-
-
84872850626
-
Age-associated changes in monocyte and innate immune activation markers occur more rapidly in HIV infected women
-
Martin GE, Gouillou M, Hearps AC, et al. Age-associated changes in monocyte and innate immune activation markers occur more rapidly in HIV infected women. PLoS One. 2013;8(1):e55279
-
(2013)
PLoS One
, vol.8
, Issue.1
, pp. e55279
-
-
Martin, G.E.1
Gouillou, M.2
Hearps, A.C.3
-
60
-
-
84862236428
-
HIV status, burden of comor-bid disease, and biomarkers of inflammation, altered coagulation, and monocyte activation
-
Armah KA, McGinnis K, Baker J, et al. HIV status, burden of comor-bid disease, and biomarkers of inflammation, altered coagulation, and monocyte activation. Clin Infect Dis. 2012;55(1):126-136
-
(2012)
Clin Infect Dis
, vol.55
, Issue.1
, pp. 126-136
-
-
Armah, K.A.1
McGinnis, K.2
Baker, J.3
-
61
-
-
77950559517
-
The macrophage: The intersection between HIV infection and atherosclerosis
-
Crowe SM, Westhorpe CL, Mukhamedova N, Jaworowski A, Sviridov D, Bukrinsky M. The macrophage: the intersection between HIV infection and atherosclerosis. JLeukoc Biol. 2010;87(4):589-598
-
(2010)
JLeukoc Biol
, vol.87
, Issue.4
, pp. 589-598
-
-
Crowe, S.M.1
Westhorpe, C.L.2
Mukhamedova, N.3
Jaworowski, A.4
Sviridov, D.5
Bukrinsky, M.6
-
62
-
-
33751062798
-
Human immunodeficiency virus impairs reverse cholesterol transport from macrophages
-
Mujawar Z, Rose H, Morrow MP, et al. Human immunodeficiency virus impairs reverse cholesterol transport from macrophages. PLoS Biol. 2006;4(11):e365
-
(2006)
PLoS Biol
, vol.4
, Issue.11
, pp. e365
-
-
Mujawar, Z.1
Rose, H.2
Morrow, M.P.3
-
63
-
-
84892369987
-
Markers of coagulation and inflammation often remain elevated in ART-treated HIV-infected patients
-
Funderburg NT. Markers of coagulation and inflammation often remain elevated in ART-treated HIV-infected patients. Curr Opin HIV AIDS. 2014;9(1):80-86
-
(2014)
Curr Opin HIV AIDS
, vol.9
, Issue.1
, pp. 80-86
-
-
Funderburg, N.T.1
-
64
-
-
20444370265
-
Impaired base excision repair and accumulation of oxidative base lesions in CD4+ T cells of HIV-infected patients
-
Aukrust P, Luna L, Ueland T, et al. Impaired base excision repair and accumulation of oxidative base lesions in CD4+ T cells of HIV-infected patients. Blood. 2005;105(12):4730-4735
-
(2005)
Blood
, vol.105
, Issue.12
, pp. 4730-4735
-
-
Aukrust, P.1
Luna, L.2
Ueland, T.3
-
65
-
-
0026716993
-
Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome
-
Grunfeld C, Pang M, Doerrler W, et al. Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. J Clin Endocrinol Metab. 1992;74(5):1045-1052
-
(1992)
J Clin Endocrinol Metab
, vol.74
, Issue.5
, pp. 1045-1052
-
-
Grunfeld, C.1
Pang, M.2
Doerrler, W.3
-
66
-
-
45249102216
-
HIV infection and high density lipo-protein metabolism
-
Rose H, Hoy J, Woolley I, et al. HIV infection and high density lipo-protein metabolism. Atherosclerosis. 2008;199(1):79-86
-
(2008)
Atherosclerosis
, vol.199
, Issue.1
, pp. 79-86
-
-
Rose, H.1
Hoy, J.2
Woolley, I.3
-
67
-
-
36348999732
-
HIV-associated dyslipidaemia: Pathogenesis and treatment
-
Oh J, Hegele RA. HIV-associated dyslipidaemia: pathogenesis and treatment. Lancet Infect Dis. 2007;7(12):787-796
-
(2007)
Lancet Infect Dis
, vol.7
, Issue.12
, pp. 787-796
-
-
Oh, J.1
Hegele, R.A.2
-
68
-
-
80052752534
-
HDLs, immunity, and atherosclerosis
-
Norata GD, Pirillo A, Catapano AL. HDLs, immunity, and atherosclerosis. Curr Opin Lipidol. 2011;22(5):410-416
-
(2011)
Curr Opin Lipidol
, vol.22
, Issue.5
, pp. 410-416
-
-
Norata, G.D.1
Pirillo, A.2
Catapano, A.L.3
-
69
-
-
84920919881
-
Percutaneous coronary intervention and surgical revascularization in HIV Database (PHD) Study Investigators. Prognostic indicators for recurrent thrombotic events in HIV-infected patients with acute coronary syndromes: Use of registry data from 12 sites in Europe, South Africa and the United States
-
D'Ascenzo F, Cerrato E, Appleton D, et al; Percutaneous coronary intervention and surgical revascularization in HIV Database (PHD) Study Investigators. Prognostic indicators for recurrent thrombotic events in HIV-infected patients with acute coronary syndromes: use of registry data from 12 sites in Europe, South Africa and the United States. Thromb Res. 2014;134(3):558-564
-
(2014)
Thromb Res
, vol.134
, Issue.3
, pp. 558-564
-
-
D'ascenzo, F.1
Cerrato, E.2
Appleton, D.3
-
70
-
-
0037463620
-
Acute myocardial infarction in human immunodeficiency virus-infected patients
-
Matetzky S, Domingo M, Kar S, et al. Acute myocardial infarction in human immunodeficiency virus-infected patients. Arch Intern Med. 2003;163(4):457-460
-
(2003)
Arch Intern Med
, vol.163
, Issue.4
, pp. 457-460
-
-
Matetzky, S.1
Domingo, M.2
Kar, S.3
-
71
-
-
33751560264
-
Outcome of percutaneous coronary intervention in HIV-infected patients
-
Segev A, Cantor WJ, Strauss BH. Outcome of percutaneous coronary intervention in HIV-infected patients. Catheter Cardiovasc Interv. 2006;68(6):879-881
-
(2006)
Catheter Cardiovasc Interv
, vol.68
, Issue.6
, pp. 879-881
-
-
Segev, A.1
Cantor, W.J.2
Strauss, B.H.3
-
72
-
-
33645233831
-
Percutaneous coronary intervention in HIV infected patients: Immediate results and long term prognosis
-
Boccara F, Teiger E, Cohen A, et al. Percutaneous coronary intervention in HIV infected patients: immediate results and long term prognosis. Heart. 2006;92(4):543-544
-
(2006)
Heart
, vol.92
, Issue.4
, pp. 543-544
-
-
Boccara, F.1
Teiger, E.2
Cohen, A.3
-
73
-
-
84920914216
-
Safety and long-term outcomes after percutaneous coronary intervention in patients with human immunodeficiency virus. Catheter Cardiovasc Interv
-
Badr S, Minha S, Kitabata H, et al. Safety and long-term outcomes after percutaneous coronary intervention in patients with human immunodeficiency virus. Catheter Cardiovasc Interv. Epub February 28, 2014
-
(2014)
Epub February
, pp. 28
-
-
Badr, S.1
Minha, S.2
Kitabata, H.3
-
74
-
-
0042768569
-
French WHO MONICA Project and the APROCO (ANRS EP11) Study Group. Risk factors for coronary heart disease in patients treated for human immunodeficiency virus infection compared with the general population
-
Saves M, Chene G, Ducimetiere P, et al; French WHO MONICA Project and the APROCO (ANRS EP11) Study Group. Risk factors for coronary heart disease in patients treated for human immunodeficiency virus infection compared with the general population. Clin Infect Dis. 2003;37(2):292-298
-
(2003)
Clin Infect Dis
, vol.37
, Issue.2
, pp. 292-298
-
-
Saves, M.1
Chene, G.2
Ducimetiere, P.3
-
75
-
-
19344373051
-
Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study
-
Brown TT, Cole SR, Li X, et al. Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study. Arch Intern Med. 2005;165(10):1179-1184
-
(2005)
Arch Intern Med
, vol.165
, Issue.10
, pp. 1179-1184
-
-
Brown, T.T.1
Cole, S.R.2
Li, X.3
-
76
-
-
0038386036
-
DAD study group. Cardiovascular disease risk factors in HIV patients-association with antiretroviral therapy. Results from the DAD study
-
Friis-M0ller N, Weber R, Reiss P, et al; DAD study group. Cardiovascular disease risk factors in HIV patients-association with antiretroviral therapy. Results from the DAD study. AIDS. 2003;17(8): 1179-1193
-
(2003)
AIDS
, vol.17
, Issue.8
, pp. 1179-1193
-
-
Friis-Moller, N.1
Weber, R.2
Reiss, P.3
-
77
-
-
1642565262
-
Cardiovascular disease risk factors and antiretroviral therapy in an HIV-positive UK population
-
Smith CJ, Levy I, Sabin CA, Kaya E, Johnson MA, Lipman MC. Cardiovascular disease risk factors and antiretroviral therapy in an HIV-positive UK population. HIV Med. 2004;5(2):88-92
-
(2004)
HIV Med
, vol.5
, Issue.2
, pp. 88-92
-
-
Smith, C.J.1
Levy, I.2
Sabin, C.A.3
Kaya, E.4
Johnson, M.A.5
Lipman, M.C.6
-
78
-
-
27344459167
-
Atherogenic lipid profile and cardiovascular risk factors in HIV-infected patients (Netar Study)
-
Santos J, Palacios R, Gonzalez M, Ruiz J, Marquez M. Atherogenic lipid profile and cardiovascular risk factors in HIV-infected patients (Netar Study). Int JSTD AIDS. 2005;16(10):677-680
-
(2005)
Int JSTD AIDS
, vol.16
, Issue.10
, pp. 677-680
-
-
Santos, J.1
Palacios, R.2
Gonzalez, M.3
Ruiz, J.4
Marquez, M.5
-
79
-
-
33746442434
-
Swiss HIV Cohort Study. Prevalence of risk factors for cardiovascular disease in HIV-infected patients over time: The Swiss HIV Cohort Study
-
Glass TR, Ungsedhapand C, Wolbers M, et al; Swiss HIV Cohort Study. Prevalence of risk factors for cardiovascular disease in HIV-infected patients over time: the Swiss HIV Cohort Study. HIV Med. 2006;7(6):404-410
-
(2006)
HIV Med
, vol.7
, Issue.6
, pp. 404-410
-
-
Glass, T.R.1
Ungsedhapand, C.2
Wolbers, M.3
-
80
-
-
34848856661
-
Ten-year predicted coronary heart disease risk in HIV-infected men and women
-
Kaplan RC, Kingsley LA, Sharrett AR, et al. Ten-year predicted coronary heart disease risk in HIV-infected men and women. Clin Infect Dis. 2007;45(8):1074-1081
-
(2007)
Clin Infect Dis
, vol.45
, Issue.8
, pp. 1074-1081
-
-
Kaplan, R.C.1
Kingsley, L.A.2
Sharrett, A.R.3
-
81
-
-
84868206824
-
Grupo de estudio de riesgo cardiovascular de CoRIS. [Cardiovascular risk in human immunodeficiency virus-infected patients in Spain. CoRIS cohort, 2011]
-
Masia M, Perez-Cachafeiro S, Leyes M, et al; Grupo de estudio de riesgo cardiovascular de CoRIS. [Cardiovascular risk in human immunodeficiency virus-infected patients in Spain. CoRIS cohort, 2011]. Enferm Infecc Microbiol Clin. 2012;30(9):517-527
-
(2012)
Enferm Infecc Microbiol Clin
, vol.30
, Issue.9
, pp. 517-527
-
-
Masia, M.1
Perez-Cachafeiro, S.2
Leyes, M.3
-
82
-
-
34447561565
-
Dietary fat intake and relationship to serum lipid levels in HIV-infected patients with metabolic abnormalities in the HAART era
-
Spanish Joy T, Keogh HM, Hadigan C, et al. Dietary fat intake and relationship to serum lipid levels in HIV-infected patients with metabolic abnormalities in the HAART era. AIDS. 2007;21(12):1591-1600
-
(2007)
AIDS
, vol.21
, Issue.12
, pp. 1591-1600
-
-
Spanish Joy, T.1
Keogh, H.M.2
Hadigan, C.3
-
83
-
-
33847073815
-
Metabolic syndrome in HIV-infected patients from an urban, midwestern US outpatient population
-
Mondy K, Overton ET, Grubb J, et al. Metabolic syndrome in HIV-infected patients from an urban, midwestern US outpatient population. Clin Infect Dis. 2007;44(5):726-734
-
(2007)
Clin Infect Dis
, vol.44
, Issue.5
, pp. 726-734
-
-
Mondy, K.1
Overton, E.T.2
Grubb, J.3
-
84
-
-
34547611656
-
Incidence and prevalence of the metabolic syndrome in a cohort of naive HIV-infected patients: Prospective analysis at 48 weeks of highly active antiretroviral therapy
-
Palacios R, Santos J, Gonzalez M, Ruiz J, Marquez M. Incidence and prevalence of the metabolic syndrome in a cohort of naive HIV-infected patients: prospective analysis at 48 weeks of highly active antiretroviral therapy. Int J STD AIDS. 2007;18(3):184-187
-
(2007)
Int J STD AIDS
, vol.18
, Issue.3
, pp. 184-187
-
-
Palacios, R.1
Santos, J.2
Gonzalez, M.3
Ruiz, J.4
Marquez, M.5
-
85
-
-
84892475095
-
African Partnership for Chronic Disease Research (APCDR). Association of HIV and ART with car-diometabolic traits in sub-Saharan Africa: A systematic review and meta-analysis
-
Dillon DG, Gurdasani D, Riha J, et al; African Partnership for Chronic Disease Research (APCDR). Association of HIV and ART with car-diometabolic traits in sub-Saharan Africa: a systematic review and meta-analysis. Int J Epidemiol. 2013;42(6):1754-1771
-
(2013)
Int J Epidemiol
, vol.42
, Issue.6
, pp. 1754-1771
-
-
Dillon, D.G.1
Gurdasani, D.2
Riha, J.3
-
86
-
-
49849095394
-
Aortic stiffness in untreated adult patients with human immunodeficiency virus infection
-
Schillaci G, De Socio GV, Pucci G, et al. Aortic stiffness in untreated adult patients with human immunodeficiency virus infection. Hypertension. 2008;52(2):308-313
-
(2008)
Hypertension
, vol.52
, Issue.2
, pp. 308-313
-
-
Schillaci, G.1
De Socio, G.V.2
Pucci, G.3
-
87
-
-
68149178673
-
Association of highly active anti-retroviral therapy with increased arterial stiffness in patients infected with human immunodeficiency virus
-
Lekakis J, Ikonomidis I, Palios J, et al. Association of highly active anti-retroviral therapy with increased arterial stiffness in patients infected with human immunodeficiency virus. Am J Hypertens. 2009;22(8): 828-834
-
(2009)
Am J Hypertens
, vol.22
, Issue.8
, pp. 828-834
-
-
Lekakis, J.1
Ikonomidis, I.2
Palios, J.3
-
88
-
-
84893775901
-
Pulse wave velocity as index of arterial stiffness in HIV-infected patients compared with a healthy population
-
Echeverria P, Bonjoch A, Moltö J, et al. Pulse wave velocity as index of arterial stiffness in HIV-infected patients compared with a healthy population. J Acquir Immune Defic Syndr. 2014;65(1):50-56
-
(2014)
J Acquir Immune Defic Syndr
, vol.65
, Issue.1
, pp. 50-56
-
-
Echeverria, P.1
Bonjoch, A.2
Moltö, J.3
-
89
-
-
84858707788
-
Chronic HCV infection is a risk of atherosclerosis. Role of HCV and HCV-related steatosis
-
Adinolfi LE, Restivo L, Zampino R, et al. Chronic HCV infection is a risk of atherosclerosis. Role of HCV and HCV-related steatosis. Atherosclerosis. 2012;221(2):496-502
-
(2012)
Atherosclerosis
, vol.221
, Issue.2
, pp. 496-502
-
-
Adinolfi, L.E.1
Restivo, L.2
Zampino, R.3
-
90
-
-
0037065523
-
Association between hepatitis C virus seropositivity, carotid-artery plaque, and intima-media thickening
-
Ishizaka N, Ishizaka Y, Takahashi E, et al. Association between hepatitis C virus seropositivity, carotid-artery plaque, and intima-media thickening. Lancet. 2002;359(9301):133-135
-
(2002)
Lancet
, vol.359
, Issue.9301
, pp. 133-135
-
-
Ishizaka, N.1
Ishizaka, Y.2
Takahashi, E.3
-
91
-
-
56849101004
-
Hepatitis C infection is associated with increased coronary artery atherosclerosis defined by modified Reardon severity score system
-
Alyan O, Kacmaz F, Ozdemir O, et al. Hepatitis C infection is associated with increased coronary artery atherosclerosis defined by modified Reardon severity score system. Circ J. 2008;72(12):1960-1965
-
(2008)
Circ J
, vol.72
, Issue.12
, pp. 1960-1965
-
-
Alyan, O.1
Kacmaz, F.2
Ozdemir, O.3
-
92
-
-
1942436227
-
Evidence for association between hepatitis C virus seropositivity and coronary artery disease
-
Vassalle C, Masini S, Bianchi F, Zucchelli GC. Evidence for association between hepatitis C virus seropositivity and coronary artery disease. Heart. 2004;90(5):565-566
-
(2004)
Heart
, vol.90
, Issue.5
, pp. 565-566
-
-
Vassalle, C.1
Masini, S.2
Bianchi, F.3
Zucchelli, G.C.4
-
93
-
-
78650419996
-
Hepatitis C virus infection and increased risk of cerebrovascular disease
-
Lee MH, Yang HI, Wang CH, et al. Hepatitis C virus infection and increased risk of cerebrovascular disease. Stroke. 2010;41(12): 2894-2900
-
(2010)
Stroke
, vol.41
, Issue.12
, pp. 2894-2900
-
-
Lee, M.H.1
Yang, H.I.2
Wang, C.H.3
-
94
-
-
84874105029
-
Associations of chronic hepatitis C with metabolic and cardiac outcomes
-
Younossi ZM, Stepanova M, Nader F, Younossi Z, Elsheikh E. Associations of chronic hepatitis C with metabolic and cardiac outcomes. Aliment Pharmacol Ther. 2013;37(6):647-652
-
(2013)
Aliment Pharmacol Ther
, vol.37
, Issue.6
, pp. 647-652
-
-
Younossi, Z.M.1
Stepanova, M.2
Nader, F.3
Younossi, Z.4
Elsheikh, E.5
-
95
-
-
84920926811
-
Hepatitis C virus infection increases the risk of Developing peripheral arterial disease: A 9-year population-based cohort study
-
Hsu YH, Muo CH, Liu CY, et al. Hepatitis C virus infection increases the risk of Developing peripheral arterial disease: a 9-year population-based cohort study. J Hepatol. Epub September 25, 2014
-
(2014)
J Hepatol. Epub September
, pp. 25
-
-
Hsu, Y.H.1
Muo, C.H.2
Liu, C.Y.3
-
96
-
-
84859849101
-
Atherosclerosis risk in HIV-infected patients: The influence of hepatitis C virus co-infection
-
Sosner P, Wangermez M, Chagneau-Derrode C, Le Moal G, Silvain C. Atherosclerosis risk in HIV-infected patients: the influence of hepatitis C virus co-infection. Atherosclerosis. 2012;222(1):274-277
-
(2012)
Atherosclerosis
, vol.222
, Issue.1
, pp. 274-277
-
-
Sosner, P.1
Wangermez, M.2
Chagneau-Derrode, C.3
Le Moal, G.4
Silvain, C.5
-
97
-
-
77955124347
-
Hepatitis C virus coinfection and the risk of cardiovascular disease among HIV-infected patients
-
Bedimo R, Westfall AO, Mugavero M, Drechsler H, Khanna N, Saag M. Hepatitis C virus coinfection and the risk of cardiovascular disease among HIV-infected patients. HIV Med. 2010;11(7):462-468
-
(2010)
HIV Med
, vol.11
, Issue.7
, pp. 462-468
-
-
Bedimo, R.1
Westfall, A.O.2
Mugavero, M.3
Drechsler, H.4
Khanna, N.5
Saag, M.6
-
98
-
-
84902658836
-
OHTN Cohort Study Group. Risk of cardiovascular disease associated with HCV and HBV coinfection among antiretroviral-treated HIV-infected individuals
-
Gillis J, Smieja M, Cescon A, et al; OHTN Cohort Study Group. Risk of cardiovascular disease associated with HCV and HBV coinfection among antiretroviral-treated HIV-infected individuals. Antivir Ther. 2014;19(3):309-317
-
(2014)
Antivir Ther
, vol.19
, Issue.3
, pp. 309-317
-
-
Gillis, J.1
Smieja, M.2
Cescon, A.3
-
99
-
-
0031439520
-
Coagulation initiated on herpesviruses
-
Sutherland MR, Raynor CM, Leenknegt H, Wright JF, Pryzdial EL. Coagulation initiated on herpesviruses. Proc Natl Acad Sci U S A. 1997;94(25):13510-13514
-
(1997)
Proc Natl Acad Sci U S A
, vol.94
, Issue.25
, pp. 13510-13514
-
-
Sutherland, M.R.1
Raynor, C.M.2
Leenknegt, H.3
Wright, J.F.4
Pryzdial, E.L.5
-
100
-
-
5044231043
-
Herpes simplex virus type 2 infection is a risk factor for hypertension
-
Sun Y, Pei W, Wu Y, Jing Z, Zhang J, Wang G. Herpes simplex virus type 2 infection is a risk factor for hypertension. Hypertens Res. 2004;27(8):541-544
-
(2004)
Hypertens Res
, vol.27
, Issue.8
, pp. 541-544
-
-
Sun, Y.1
Pei, W.2
Wu, Y.3
Jing, Z.4
Zhang, J.5
Wang, G.6
-
101
-
-
0036140702
-
AtheroGene Investigators. Impact of infectious burden on extent and long-term prognosis of atherosclerosis
-
Espinola-Klein C, Rupprecht HJ, Blankenberg S, et al; AtheroGene Investigators. Impact of infectious burden on extent and long-term prognosis of atherosclerosis. Circulation. 2002;105(1):15-21
-
(2002)
Circulation
, vol.105
, Issue.1
, pp. 15-21
-
-
Espinola-Klein, C.1
Rupprecht, H.J.2
Blankenberg, S.3
-
102
-
-
33751227183
-
Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responses
-
Hsue PY, Hunt PW, Sinclair E, et al. Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responses. AIDS. 2006;20(18):2275-2283
-
(2006)
AIDS
, vol.20
, Issue.18
, pp. 2275-2283
-
-
Hsue, P.Y.1
Hunt, P.W.2
Sinclair, E.3
-
103
-
-
84861553601
-
Cytomegalovirus immu-noglobulin G antibody is associated with subclinical carotid artery disease among HIV-infected women
-
Parrinello CM, Sinclair E, Landay AL, et al. Cytomegalovirus immu-noglobulin G antibody is associated with subclinical carotid artery disease among HIV-infected women. J Infect Dis. 2012;205(12): 1788-1796
-
(2012)
J Infect Dis
, vol.205
, Issue.12
, pp. 1788-1796
-
-
Parrinello, C.M.1
Sinclair, E.2
Landay, A.L.3
-
104
-
-
84864767476
-
Herpes simplex virus type 2 (HSV-2) as a coronary atherosclerosis risk factor in HIV-infected men: Multicenter AIDS cohort study
-
Hechter RC, Budoff M, Hodis HN, et al. Herpes simplex virus type 2 (HSV-2) as a coronary atherosclerosis risk factor in HIV-infected men: multicenter AIDS cohort study. Atherosclerosis. 2012;223(2): 433-436
-
(2012)
Atherosclerosis
, vol.223
, Issue.2
, pp. 433-436
-
-
Hechter, R.C.1
Budoff, M.2
Hodis, H.N.3
-
105
-
-
84858729168
-
Relative risk of renal disease among people living with HIV: A systematic review and meta-analysis
-
Islam FM, Wu J, Jansson J, Wilson DP. Relative risk of renal disease among people living with HIV: a systematic review and meta-analysis. BMC Public Health. 2012;12:234
-
(2012)
BMC Public Health
, vol.12
, pp. 234
-
-
Islam, F.M.1
Wu, J.2
Jansson, J.3
Wilson, D.P.4
-
106
-
-
84858991455
-
Renal complications in HIV disease: Between present and future
-
Maggi P, Bartolozzi D, Bonfanti P, et al. Renal complications in HIV disease: between present and future. AIDS Rev. 2012;14(1):37-53
-
(2012)
AIDS Rev
, vol.14
, Issue.1
, pp. 37-53
-
-
Maggi, P.1
Bartolozzi, D.2
Bonfanti, P.3
-
107
-
-
39849088865
-
Suppression of HIV-1 replication by antiretroviral therapy improves renal function in persons with low CD4 cell counts and chronic kidney disease
-
Kalayjian RC, Franceschini N, Gupta SK, et al. Suppression of HIV-1 replication by antiretroviral therapy improves renal function in persons with low CD4 cell counts and chronic kidney disease. AIDS. 2008; 22(4):481-487
-
(2008)
AIDS
, vol.22
, Issue.4
, pp. 481-487
-
-
Kalayjian, R.C.1
Franceschini, N.2
Gupta, S.K.3
-
108
-
-
77954189731
-
HIV-infected persons continue to lose kidney function despite successful antiretro-viral therapy
-
Choi AI, Shlipak MG, Hunt PW, Martin JN, Deeks SG. HIV-infected persons continue to lose kidney function despite successful antiretro-viral therapy. AIDS. 2009;23(16):2143-2149
-
(2009)
AIDS
, vol.23
, Issue.16
, pp. 2143-2149
-
-
Choi, A.I.1
Shlipak, M.G.2
Hunt, P.W.3
Martin, J.N.4
Deeks, S.G.5
-
109
-
-
84866737068
-
Risk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine care
-
Kalayjian RC, Lau B, Mechekano RN, et al. Risk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine care. AIDS. 2012;26(15): 1907-1915
-
(2012)
AIDS
, vol.26
, Issue.15
, pp. 1907-1915
-
-
Kalayjian, R.C.1
Lau, B.2
Mechekano, R.N.3
-
110
-
-
77952571995
-
Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection
-
Neuhaus J, Jacobs DR, Baker JV et al. Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection. JInfect Dis. 2010;201(12):1788-1795
-
(2010)
JInfect Dis
, vol.201
, Issue.12
, pp. 1788-1795
-
-
Neuhaus, J.1
Jacobs, D.R.2
Baker, J.V.3
-
111
-
-
64249131548
-
Plasma levels of VCAM-1, ICAM-1, E-Selectin, and P-Selectin in 99 HIV-positive patients versus 51 HIV-negative healthy controls
-
Calza L, Pocaterra D, Pavoni M, et al. Plasma levels of VCAM-1, ICAM-1, E-Selectin, and P-Selectin in 99 HIV-positive patients versus 51 HIV-negative healthy controls. J Acquir Immune Defic Syndr. 2009;50(4):430-432
-
(2009)
J Acquir Immune Defic Syndr
, vol.50
, Issue.4
, pp. 430-432
-
-
Calza, L.1
Pocaterra, D.2
Pavoni, M.3
-
112
-
-
39749119864
-
Endothelial adhesion molecules are associated with inflammation in subjects with HIV disease
-
Melendez MM, McNurlan MA, Mynarcik DC, Khan S, Gelato MC. Endothelial adhesion molecules are associated with inflammation in subjects with HIV disease. Clin Infect Dis. 2008;46(5):775-780
-
(2008)
Clin Infect Dis
, vol.46
, Issue.5
, pp. 775-780
-
-
Melendez, M.M.1
McNurlan, M.A.2
Mynarcik, D.C.3
Khan, S.4
Gelato, M.C.5
-
113
-
-
84892736363
-
Rate and predictors of carotid artery intima media thickness progression in antiretroviral-naive HIV-infected and uninfected adults: A 48-week matched prospective cohort study
-
Hileman CO, Carman TL, Longenecker CT, et al. Rate and predictors of carotid artery intima media thickness progression in antiretroviral-naive HIV-infected and uninfected adults: a 48-week matched prospective cohort study. Antivir Ther. 2013;18(7):921-929
-
(2013)
Antivir Ther
, vol.18
, Issue.7
, pp. 921-929
-
-
Hileman, C.O.1
Carman, T.L.2
Longenecker, C.T.3
-
114
-
-
70350044725
-
Plasma concentrations of the cardiovascular risk factor asymmetric dimethylarginine (ADMA) are increased in patients with HIV-1 infection and correlate with immune activation markers
-
Kurz K, Teerlink T, Sarcletti M, Weiss G, Zangerle R, Fuchs D. Plasma concentrations of the cardiovascular risk factor asymmetric dimethylarginine (ADMA) are increased in patients with HIV-1 infection and correlate with immune activation markers. Pharmacol Res. 2009;60(6):508-514
-
(2009)
Pharmacol Res
, vol.60
, Issue.6
, pp. 508-514
-
-
Kurz, K.1
Teerlink, T.2
Sarcletti, M.3
Weiss, G.4
Zangerle, R.5
Fuchs, D.6
-
115
-
-
67651065515
-
Association of C-reactive protein and HIV infection with acute myocardial infarction
-
Triant VA, Meigs JB, Grinspoon SK. Association of C-reactive protein and HIV infection with acute myocardial infarction. J Acquir Immune Defic Syndr. 2009;51(3):268-273
-
(2009)
J Acquir Immune Defic Syndr
, vol.51
, Issue.3
, pp. 268-273
-
-
Triant, V.A.1
Meigs, J.B.2
Grinspoon, S.K.3
-
116
-
-
55949084601
-
INSIGHT SMART Study Group. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection
-
Kuller LH, Tracy R, Belloso W, et al; INSIGHT SMART Study Group. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med. 2008;5(10):e203
-
(2008)
PLoS Med
, vol.5
, Issue.10
, pp. e203
-
-
Kuller, L.H.1
Tracy, R.2
Belloso, W.3
-
117
-
-
84871234436
-
INSIGHT SMART Study Group. Inflammation, coagulation and cardiovascular disease in HIV-infected individuals
-
Duprez DA, Neuhaus J, Kuller LH, et al; INSIGHT SMART Study Group. Inflammation, coagulation and cardiovascular disease in HIV-infected individuals. PLoS One. 2012;7(9):e44454
-
(2012)
PLoS One
, vol.7
, Issue.9
, pp. e44454
-
-
Duprez, D.A.1
Neuhaus, J.2
Kuller, L.H.3
-
118
-
-
84920875622
-
INSIGHT SMART, ESPRIT Study Groups; SILCAAT Scientific Committee. Severity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulation
-
Nordell AD, McKenna M, Borges ÂH, Duprez D, Neuhaus J, Neaton JD; INSIGHT SMART, ESPRIT Study Groups; SILCAAT Scientific Committee. Severity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulation. J Am Heart Assoc. 2014;3(3):000844
-
(2014)
J Am Heart Assoc
, vol.3
, Issue.3
, pp. 000844
-
-
Nordell, A.D.1
McKenna, M.2
Borges, Â.3
Duprez, D.4
Neuhaus, J.5
Neaton, J.D.6
-
119
-
-
84910010874
-
Soluble markers of inflammation and coagulation but not T-cell activation predict non-AIDS-defining morbid events during suppressive antiretroviral treatment
-
Tenorio AR, Zheng Y, Bosch RJ, et al. Soluble markers of inflammation and coagulation but not T-cell activation predict non-AIDS-defining morbid events during suppressive antiretroviral treatment. J Infect Dis. 2014;210(8):1248-1259
-
(2014)
J Infect Dis
, vol.210
, Issue.8
, pp. 1248-1259
-
-
Tenorio, A.R.1
Zheng, Y.2
Bosch, R.J.3
-
120
-
-
84878903029
-
Markers of inflammation and CD8 T-cell activation, but not monocyte activation, are associated with subclinical carotid artery disease in HIV-infected individuals
-
Longenecker CT, Funderburg NT, Jiang Y, et al. Markers of inflammation and CD8 T-cell activation, but not monocyte activation, are associated with subclinical carotid artery disease in HIV-infected individuals. HIV Med. 2013;14(6):385-390
-
(2013)
HIV Med
, vol.14
, Issue.6
, pp. 385-390
-
-
Longenecker, C.T.1
Funderburg, N.T.2
Jiang, Y.3
-
121
-
-
70349923389
-
Relationship between inflammatory markers, endothelial activation markers, and carotid intima-media thickness in HIV-infected patients receiving antiretroviral therapy
-
Ross AC, Rizk N, O'Riordan MA, et al. Relationship between inflammatory markers, endothelial activation markers, and carotid intima-media thickness in HIV-infected patients receiving antiretroviral therapy. Clin Infect Dis. 2009;49(7):1119-1127
-
(2009)
Clin Infect Dis
, vol.49
, Issue.7
, pp. 1119-1127
-
-
Ross, A.C.1
Rizk, N.2
O'riordan, M.A.3
-
122
-
-
79960698033
-
Asymmetric dimethylarginine and coronary artery calcium scores are increased in patients infected with human immunodeficiency virus
-
Jang JJ, Berkheimer SB, Merchant M, Krishnaswami A. Asymmetric dimethylarginine and coronary artery calcium scores are increased in patients infected with human immunodeficiency virus. Atherosclerosis. 2011;217(2):514-517
-
(2011)
Atherosclerosis
, vol.217
, Issue.2
, pp. 514-517
-
-
Jang, J.J.1
Berkheimer, S.B.2
Merchant, M.3
Krishnaswami, A.4
-
123
-
-
79957940339
-
Soluble CD163 made by monocyte/macrophages is a novel marker of HIV activity in early and chronic infection prior to and after anti-retroviral therapy
-
Burdo TH, Lentz MR, Autissier P, et al. Soluble CD163 made by monocyte/macrophages is a novel marker of HIV activity in early and chronic infection prior to and after anti-retroviral therapy. J Infect Dis. 2011;204(1):154-163
-
(2011)
J Infect Dis
, vol.204
, Issue.1
, pp. 154-163
-
-
Burdo, T.H.1
Lentz, M.R.2
Autissier, P.3
-
124
-
-
84897053488
-
Reduced sTWEAK and increased sCD163 levels in HIV-infected patients: Modulation by antiretroviral treatment, HIV replication and HCV co-infection
-
Beltran LM, Munoz Hernandez R, de Pablo Bernal RS, et al. Reduced sTWEAK and increased sCD163 levels in HIV-infected patients: modulation by antiretroviral treatment, HIV replication and HCV co-infection. PLoS One. 2014;9(3):e90541
-
(2014)
PLoS One
, vol.9
, Issue.3
, pp. e90541
-
-
Beltran, L.M.1
Munoz Hernandez, R.2
De Pablo Bernal, R.S.3
-
125
-
-
80052899856
-
Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patients
-
Burdo TH, Lo J, Abbara S, et al. Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patients. J Infect Dis. 2011;204(8): 1227-1236
-
(2011)
J Infect Dis
, vol.204
, Issue.8
, pp. 1227-1236
-
-
Burdo, T.H.1
Lo, J.2
Abbara, S.3
-
126
-
-
84888611154
-
Noncalcified coronary atherosclerotic plaque and immune activation in HIV-infected women
-
Fitch KV, Srinivasa S, Abbara S, et al. Noncalcified coronary atherosclerotic plaque and immune activation in HIV-infected women. J Infect Dis. 2013;208(11):1737-1746
-
(2013)
J Infect Dis
, vol.208
, Issue.11
, pp. 1737-1746
-
-
Fitch, K.V.1
Srinivasa, S.2
Abbara, S.3
-
127
-
-
84864138716
-
Arterial inflammation in patients with HIV
-
Subramanian S, Tawakol A, Burdo TH, et al. Arterial inflammation in patients with HIV. JAMA. 2012;308(4):379-386
-
(2012)
JAMA
, vol.308
, Issue.4
, pp. 379-386
-
-
Subramanian, S.1
Tawakol, A.2
Burdo, T.H.3
-
128
-
-
84897498055
-
Soluble CD14 is independently associated with coronary calcification and extent of sub-clinical vascular disease in treated HIV infection
-
Longenecker CT, Jiang Y, Orringer CE, et al. Soluble CD14 is independently associated with coronary calcification and extent of sub-clinical vascular disease in treated HIV infection. AIDS. 2014;28(7): 969-977
-
(2014)
AIDS
, vol.28
, Issue.7
, pp. 969-977
-
-
Longenecker, C.T.1
Jiang, Y.2
Orringer, C.E.3
-
129
-
-
84898012819
-
CDC SUN Study Investigators. Immunologic predictors of coronary artery calcium progression in a contemporary HIV cohort
-
Baker JV Hullsiek KH, Singh A, et al; CDC SUN Study Investigators. Immunologic predictors of coronary artery calcium progression in a contemporary HIV cohort. AIDS. 2014;28(6):831-840
-
(2014)
AIDS
, vol.28
, Issue.6
, pp. 831-840
-
-
Baker Jv Hullsiek, K.H.1
Singh, A.2
-
130
-
-
65649083543
-
Reduction in circulating markers of endothelial dysfunction in HIV-infected patients during antiretroviral therapy
-
Kristoffersen US, Kofoed K, Kronborg G, Giger AK, Kjaer A, Lebech AM. Reduction in circulating markers of endothelial dysfunction in HIV-infected patients during antiretroviral therapy. HIV Med. 2009;10(2):79-87
-
(2009)
HIV Med
, vol.10
, Issue.2
, pp. 79-87
-
-
Kristoffersen, U.S.1
Kofoed, K.2
Kronborg, G.3
Giger, A.K.4
Kjaer, A.5
Lebech, A.M.6
-
131
-
-
84863723979
-
Inflammation markers after randomization to abacavir/lamivudine or tenofovir/emtricitabine with efavirenz or atazanavir/ritonavir
-
McComsey GA, Kitch D, Daar ES, et al. Inflammation markers after randomization to abacavir/lamivudine or tenofovir/emtricitabine with efavirenz or atazanavir/ritonavir. AIDS. 2012;26(11):1371-1385
-
(2012)
AIDS
, vol.26
, Issue.11
, pp. 1371-1385
-
-
McComsey, G.A.1
Kitch, D.2
Daar, E.S.3
-
132
-
-
67049172548
-
STACCATO Study Group. HIV increases markers of cardiovascular risk: Results from a randomized, treatment interruption trial
-
Calmy A, Gayet-Ageron A, Montecucco F, et al; STACCATO Study Group. HIV increases markers of cardiovascular risk: results from a randomized, treatment interruption trial. AIDS. 2009;23(8): 929-939
-
(2009)
AIDS
, vol.23
, Issue.8
, pp. 929-939
-
-
Calmy, A.1
Gayet-Ageron, A.2
Montecucco, F.3
-
133
-
-
0037083174
-
Cohort Study. Antiretroviral therapy reduces markers of endothelial and coagulation activation in patients infected with human immunodeficiency virus type 1
-
Wolf K, Tsakiris DA, Weber R, Erb P, Battegay M; Swiss HIV Cohort Study. Antiretroviral therapy reduces markers of endothelial and coagulation activation in patients infected with human immunodeficiency virus type 1. J Infect Dis. 2002;185(4):456-462
-
(2002)
J Infect Dis
, vol.185
, Issue.4
, pp. 456-462
-
-
Wolf, K.1
Tsakiris, D.A.2
Weber, R.3
Erb, P.4
Battegay, M.5
Swiss, H.I.V.6
-
134
-
-
84865737063
-
Asymmetric dimethylarginine concentrations decrease in patients with HIV infection under antiretroviral therapy
-
Kurz K, Teerlink T, Sarcletti M, Weiss G, Zangerle R, Fuchs D. Asymmetric dimethylarginine concentrations decrease in patients with HIV infection under antiretroviral therapy. Antivir Ther. 2012;17(6):1021-1027
-
(2012)
Antivir Ther
, vol.17
, Issue.6
, pp. 1021-1027
-
-
Kurz, K.1
Teerlink, T.2
Sarcletti, M.3
Weiss, G.4
Zangerle, R.5
Fuchs, D.6
-
135
-
-
84862155139
-
INSIGHT SMART Study Group. HIV replication, inflammation, and the effect of starting antiretroviral therapy on plasma asymmetric dimethylarginine, a novel marker of endothelial dysfunction
-
Baker JV Neuhaus J, Duprez D, et al; INSIGHT SMART Study Group. HIV replication, inflammation, and the effect of starting antiretroviral therapy on plasma asymmetric dimethylarginine, a novel marker of endothelial dysfunction. J Acquir Immune Defic Syndr. 2012;60(2): 128-134
-
(2012)
J Acquir Immune Defic Syndr
, vol.60
, Issue.2
, pp. 128-134
-
-
Baker Jv Neuhaus, J.1
Duprez, D.2
-
136
-
-
33244484141
-
Normal CD16 expression and phagocytosis of Mycobacterium avium complex by monocytes from a current cohort of HIV-1-infected patients
-
Jaworowski A, Ellery P, Maslin CL, et al. Normal CD16 expression and phagocytosis of Mycobacterium avium complex by monocytes from a current cohort of HIV-1-infected patients. J Infect Dis. 2006;193(5): 693-697
-
(2006)
J Infect Dis
, vol.193
, Issue.5
, pp. 693-697
-
-
Jaworowski, A.1
Ellery, P.2
Maslin, C.L.3
-
137
-
-
84857159899
-
A plasma biomarker signature of immune activation in HIV patients on antiretroviral therapy
-
Kamat A, Misra V, Cassol E, et al. A plasma biomarker signature of immune activation in HIV patients on antiretroviral therapy. PLoS One. 2012;7(2):e30881
-
(2012)
PLoS One
, vol.7
, Issue.2
, pp. e30881
-
-
Kamat, A.1
Misra, V.2
Cassol, E.3
-
138
-
-
84899967128
-
Circulating biomarkers of immune activation distinguish viral suppression from nonsuppression in HAART-treated patients with advanced HIV-1 subtype C infection
-
Malherbe G, Steel HC, Cassol S, et al. Circulating biomarkers of immune activation distinguish viral suppression from nonsuppression in HAART-treated patients with advanced HIV-1 subtype C infection. Mediators Inflamm. 2014;2014:198413
-
(2014)
Mediators Inflamm
-
-
Malherbe, G.1
Steel, H.C.2
Cassol, S.3
-
139
-
-
84887290531
-
Prospective antiretroviral treatment of asymptomatic, HIV-1 infected controllers
-
Hatano H, Yukl SA, Ferre AL, et al. Prospective antiretroviral treatment of asymptomatic, HIV-1 infected controllers. PLoS Pathog. 2013;9(10):e1003691
-
(2013)
PLoS Pathog
, vol.9
, Issue.10
, pp. e1003691
-
-
Hatano, H.1
Yukl, S.A.2
Ferre, A.L.3
-
140
-
-
67651125105
-
Role of viral replication, antiretro-viral therapy, and immunodeficiency in HIV-associated atherosclerosis
-
Hsue PY, Hunt PW, Schnell A, et al. Role of viral replication, antiretro-viral therapy, and immunodeficiency in HIV-associated atherosclerosis. AIDS. 2009;23(9):1059-1067
-
(2009)
AIDS
, vol.23
, Issue.9
, pp. 1059-1067
-
-
Hsue, P.Y.1
Hunt, P.W.2
Schnell, A.3
-
141
-
-
84870251319
-
Increased coronary atherosclerosis and immune activation in HIV-1 elite controllers
-
Pereyra F, Lo J, Triant VA, et al. Increased coronary atherosclerosis and immune activation in HIV-1 elite controllers. AIDS. 2012;26(18): 2409-2412
-
(2012)
AIDS
, vol.26
, Issue.18
, pp. 2409-2412
-
-
Pereyra, F.1
Lo, J.2
Triant, V.A.3
-
142
-
-
84862794669
-
The association of CD4+ T-cell counts and cardiovascular risk in treated HIV disease
-
Ho JE, Scherzer R, Hecht FM, et al. The association of CD4+ T-cell counts and cardiovascular risk in treated HIV disease. AIDS. 2012;26(9):1115-1120
-
(2012)
AIDS
, vol.26
, Issue.9
, pp. 1115-1120
-
-
Ho, J.E.1
Scherzer, R.2
Hecht, F.M.3
-
143
-
-
84857046136
-
ATHENA national observational cohort study. Long-term complications in patients with poor immunological recovery despite virological successful HAART in Dutch ATHENA cohort
-
van Lelyveld SF, Gras L, Kesselring A, et al; ATHENA national observational cohort study. Long-term complications in patients with poor immunological recovery despite virological successful HAART in Dutch ATHENA cohort. AIDS. 2012;26(4):465-t74
-
(2012)
AIDS
, vol.4
, Issue.26
, pp. 74-465
-
-
Van Lelyveld, S.F.1
Gras, L.2
Kesselring, A.3
-
144
-
-
84887987230
-
Low baseline CD4+ count is associated with greater bone mineral density loss after antiretroviral therapy initiation
-
Grant PM, Kitch D, McComsey GA, et al. Low baseline CD4+ count is associated with greater bone mineral density loss after antiretroviral therapy initiation. Clin Infect Dis. 2013;57(10):1483-1488
-
(2013)
Clin Infect Dis
, vol.57
, Issue.10
, pp. 1483-1488
-
-
Grant, P.M.1
Kitch, D.2
McComsey, G.A.3
-
145
-
-
84879520476
-
The Th17/Treg ratio, IL-1RA and sCD14 levels in primary HIV infection predict the T-cell activation set point in the absence of systemic microbial translocation
-
Chevalier MF, Petitjean G, Dunyach-Remy C, et al. The Th17/Treg ratio, IL-1RA and sCD14 levels in primary HIV infection predict the T-cell activation set point in the absence of systemic microbial translocation. PLoSPathog. 2013;9(6):e1003453
-
(2013)
PLoSPathog
, vol.9
, Issue.6
, pp. e1003453
-
-
Chevalier, M.F.1
Petitjean, G.2
Dunyach-Remy, C.3
-
146
-
-
84876409568
-
Antiretroviral therapy initiated during acute HIV infection fails to prevent persistent T-cell activation
-
Vinikoor MJ, Cope A, Gay CL, et al. Antiretroviral therapy initiated during acute HIV infection fails to prevent persistent T-cell activation. J Acquir Immune Defic Syndr. 2013;62(5):505-508
-
(2013)
J Acquir Immune Defic Syndr
, vol.62
, Issue.5
, pp. 505-508
-
-
Vinikoor, M.J.1
Cope, A.2
Gay, C.L.3
-
147
-
-
84885058930
-
Antiretroviral therapy initiated within 6 months of HIV infection is associated with lower T-cell activation and smaller HIV reservoir size
-
Jain V, Hartogensis W, Bacchetti P, et al. Antiretroviral therapy initiated within 6 months of HIV infection is associated with lower T-cell activation and smaller HIV reservoir size. J Infect Dis. 2013;208(8): 1202-1211
-
(2013)
J Infect Dis
, vol.208
, Issue.8
, pp. 1202-1211
-
-
Jain, V.1
Hartogensis, W.2
Bacchetti, P.3
-
148
-
-
84866951694
-
A pilot trial of adding maraviroc to suppressive antiretroviral therapy for suboptimal CD4+ T-cell recovery despite sustained virologic suppression: ACTG A5256
-
Wilkin TJ, Lalama CM, McKinnon J, et al. A pilot trial of adding maraviroc to suppressive antiretroviral therapy for suboptimal CD4+ T-cell recovery despite sustained virologic suppression: ACTG A5256. J Infect Dis. 2012;206(4):534-542
-
(2012)
J Infect Dis
, vol.206
, Issue.4
, pp. 534-542
-
-
Wilkin, T.J.1
Lalama, C.M.2
McKinnon, J.3
-
149
-
-
84880421532
-
The immunologic effects of maraviroc intensification in treated HIV-infected individuals with incomplete CD4+ T-cell recovery: A randomized trial
-
Hunt PW, Shulman NS, Hayes TL, et al. The immunologic effects of maraviroc intensification in treated HIV-infected individuals with incomplete CD4+ T-cell recovery: a randomized trial. Blood. 2013;121(23):4635-t646
-
(2013)
Blood
, vol.121
, Issue.23
, pp. 646-4635
-
-
Hunt, P.W.1
Shulman, N.S.2
Hayes, T.L.3
-
150
-
-
84870242082
-
Raltegravir intensification shows differing effects on CD8 and CD4 T cells in HIV-infected HAART-suppressed individuals with poor CD4 T-cell recovery
-
Massanella M, Negredo E, Puig J, et al. Raltegravir intensification shows differing effects on CD8 and CD4 T cells in HIV-infected HAART-suppressed individuals with poor CD4 T-cell recovery. AIDS. 2012;26(18):2285-2293
-
(2012)
AIDS
, vol.26
, Issue.18
, pp. 2285-2293
-
-
Massanella, M.1
Negredo, E.2
Puig, J.3
-
151
-
-
85027920222
-
WuY, et al. A randomized controlled trial assessing the effects of raltegravir intensification on endothelial function in treated HIV infection
-
Hatano H, Scherzer R, WuY, et al. A randomized controlled trial assessing the effects of raltegravir intensification on endothelial function in treated HIV infection. J Acquir Immune Defic Syndr. 2012;61(3):317-325
-
(2012)
J Acquir Immune Defic Syndr
, vol.61
, Issue.3
, pp. 317-325
-
-
Hatano, H.1
Scherzer, R.2
-
152
-
-
84885411247
-
Increase in 2-long terminal repeat circles and decrease in D-dimer after raltegravir intensification in patients with treated HIV infection: A randomized, placebo-controlled trial
-
Hatano H, Strain MC, Scherzer R, et al. Increase in 2-long terminal repeat circles and decrease in D-dimer after raltegravir intensification in patients with treated HIV infection: a randomized, placebo-controlled trial. J Infect Dis. 2013;208(9):1436-1442
-
(2013)
J Infect Dis
, vol.208
, Issue.9
, pp. 1436-1442
-
-
Hatano, H.1
Strain, M.C.2
Scherzer, R.3
-
153
-
-
84883225615
-
ANRS 138 EASIER Study Group. Decreases in inflammatory and coagulation biomarkers levels in HIV-infected patients switching from enfuvirtide to raltegravir: ANRS 138 substudy
-
Silva EF, Charreau I, Gourmel B, et al; ANRS 138 EASIER Study Group. Decreases in inflammatory and coagulation biomarkers levels in HIV-infected patients switching from enfuvirtide to raltegravir: ANRS 138 substudy. J Infect Dis. 2013;208(6):892-897
-
(2013)
J Infect Dis
, vol.208
, Issue.6
, pp. 892-897
-
-
Silva, E.F.1
Charreau, I.2
Gourmel, B.3
-
154
-
-
84870250695
-
SPIRAL Trial Group. Changes in cardiovascular biomarkers in HIV-infected patients switching from ritonavir-boosted protease inhibitors to raltegravir
-
Martinez E, D'Albuquerque PM, Llibre JM, et al; SPIRAL Trial Group. Changes in cardiovascular biomarkers in HIV-infected patients switching from ritonavir-boosted protease inhibitors to raltegravir. AIDS. 2012;26(18):2315-2326
-
(2012)
AIDS
, vol.26
, Issue.18
, pp. 2315-2326
-
-
Martinez, E.1
D'albuquerque, P.M.2
Llibre, J.M.3
-
155
-
-
84872370311
-
Endothelial function in HIV-infected patients switching from a boosted protease inhibitor-based regimen to raltegravir: A substudy of the SPIRAL study
-
Masia M, Martinez E, Padilla S, Gatell JM, Gutierrez F. Endothelial function in HIV-infected patients switching from a boosted protease inhibitor-based regimen to raltegravir: a substudy of the SPIRAL study. J Antimicrob Chemother. 2013;68(2):409-413
-
(2013)
J Antimicrob Chemother
, vol.68
, Issue.2
, pp. 409-413
-
-
Masia, M.1
Martinez, E.2
Padilla, S.3
Gatell, J.M.4
Gutierrez, F.5
-
156
-
-
84871703067
-
Microbial translocation, immune activation, and HIV disease
-
Klatt NR, Funderburg NT, Brenchley JM. Microbial translocation, immune activation, and HIV disease. Trends Microbiol. 2013;21(1): 6-13
-
(2013)
Trends Microbiol
, vol.21
, Issue.1
, pp. 6-13
-
-
Klatt, N.R.1
Funderburg, N.T.2
Brenchley, J.M.3
-
157
-
-
33845532053
-
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
-
Brenchley JM, Price DA, Schacker TW, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med. 2006;12(12):1365-1371
-
(2006)
Nat Med
, vol.12
, Issue.12
, pp. 1365-1371
-
-
Brenchley, J.M.1
Price, D.A.2
Schacker, T.W.3
-
158
-
-
84879317212
-
Immune restoration after antiretroviral therapy: The pitfalls of hasty or incomplete repairs
-
Wilson EM, Sereti I. Immune restoration after antiretroviral therapy: the pitfalls of hasty or incomplete repairs. Immunol Rev. 2013;254(1):343-354
-
(2013)
Immunol Rev
, vol.254
, Issue.1
, pp. 343-354
-
-
Wilson, E.M.1
Sereti, I.2
-
159
-
-
4644289983
-
Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract
-
Mehandru S, Poles MA, Tenner-Racz K, et al. Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract. J Exp Med. 2004;200(6):761-770
-
(2004)
J Exp Med
, vol.200
, Issue.6
, pp. 761-770
-
-
Mehandru, S.1
Poles, M.A.2
Tenner-Racz, K.3
-
160
-
-
84855417479
-
Altered CD4+ T cell homing to the gut impairs mucosal immune reconstitution in treated HIV-infected individuals
-
Mavigner M, Cazabat M, Dubois M, et al. Altered CD4+ T cell homing to the gut impairs mucosal immune reconstitution in treated HIV-infected individuals. J Clin Invest. 2012;122(1):62-69
-
(2012)
J Clin Invest
, vol.122
, Issue.1
, pp. 62-69
-
-
Mavigner, M.1
Cazabat, M.2
Dubois, M.3
-
161
-
-
84884907623
-
Inflammation and immune system interactions in atherosclerosis
-
Legein B, Temmerman L, Biessen EA, Lutgens E. Inflammation and immune system interactions in atherosclerosis. Cell Mol Life Sci. 2013;70(20):3847-69
-
(2013)
Cell Mol Life Sci
, vol.70
, Issue.20
, pp. 3847-3869
-
-
Legein, B.1
Temmerman, L.2
Biessen, E.A.3
Lutgens, E.4
-
162
-
-
84893332288
-
Rosuvastatin treatment reduces markers of monocyte activation in HIV-infected subjects on antiretroviral therapy
-
Funderburg NT, Jiang Y, Debanne SM, et al. Rosuvastatin treatment reduces markers of monocyte activation in HIV-infected subjects on antiretroviral therapy. Clin Infect Dis. 2014;58(4):588-595
-
(2014)
Clin Infect Dis
, vol.58
, Issue.4
, pp. 588-595
-
-
Funderburg, N.T.1
Jiang, Y.2
Debanne, S.M.3
-
163
-
-
84897447775
-
Effect of 24 weeks of statin therapy on systemic and vascular inflammation in HIV-infected subjects receiving antiretroviral therapy
-
Eckard AR, Jiang Y, Debanne SM, Funderburg NT, McComsey GA. Effect of 24 weeks of statin therapy on systemic and vascular inflammation in HIV-infected subjects receiving antiretroviral therapy. JInfect Dis. 2014;209(8):1156-1164
-
(2014)
JInfect Dis
, vol.209
, Issue.8
, pp. 1156-1164
-
-
Eckard, A.R.1
Jiang, Y.2
Debanne, S.M.3
Funderburg, N.T.4
McComsey, G.A.5
-
164
-
-
0030956673
-
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
-
Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997;336(14):973-979
-
(1997)
N Engl J Med
, vol.336
, Issue.14
, pp. 973-979
-
-
Ridker, P.M.1
Cushman, M.2
Stampfer, M.J.3
Tracy, R.P.4
Hennekens, C.H.5
-
165
-
-
0034704893
-
C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
-
Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000;342(12):836-843
-
(2000)
N Engl J Med
, vol.342
, Issue.12
, pp. 836-843
-
-
Ridker, P.M.1
Hennekens, C.H.2
Buring, J.E.3
Rifai, N.4
-
166
-
-
0037469255
-
C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: An 8-year follow-up of 14 719 initially healthy American women
-
Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation. 2003;107(3):391-397
-
(2003)
Circulation
, vol.107
, Issue.3
, pp. 391-397
-
-
Ridker, P.M.1
Buring, J.E.2
Cook, N.R.3
Rifai, N.4
-
167
-
-
28344441841
-
Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study
-
Ballantyne CM, Hoogeveen RC, Bang H, et al. Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study. Arch Intern Med. 2005;165(21):2479-2484
-
(2005)
Arch Intern Med
, vol.165
, Issue.21
, pp. 2479-2484
-
-
Ballantyne, C.M.1
Hoogeveen, R.C.2
Bang, H.3
-
168
-
-
77953961133
-
Traditional risk factors and D-dimer predict incident cardiovascular disease events in chronic HIV infection
-
Ford ES, Greenwald JH, Richterman AG, et al. Traditional risk factors and D-dimer predict incident cardiovascular disease events in chronic HIV infection. AIDS. 2010;24(10):1509-1517
-
(2010)
AIDS
, vol.24
, Issue.10
, pp. 1509-1517
-
-
Ford, E.S.1
Greenwald, J.H.2
Richterman, A.G.3
-
169
-
-
0042510462
-
Inflammatory markers and cardiovascular disease (The Health, Aging and Body Composition [Health ABC] Study)
-
Cesari M, Penninx BW, Newman AB, et al. Inflammatory markers and cardiovascular disease (The Health, Aging and Body Composition [Health ABC] Study). Am J Cardiol. 2003;92(5):522-528
-
(2003)
Am J Cardiol
, vol.92
, Issue.5
, pp. 522-528
-
-
Cesari, M.1
Penninx, B.W.2
Newman, A.B.3
-
170
-
-
33745827409
-
An assessment of incremental coronary risk prediction using C-reactive protein and other novel risk markers: The atherosclerosis risk in communities study
-
Folsom AR, Chambless LE, Ballantyne CM, et al. An assessment of incremental coronary risk prediction using C-reactive protein and other novel risk markers: the atherosclerosis risk in communities study. Arch Intern Med. 2006;166(13):1368-1373
-
(2006)
Arch Intern Med
, vol.166
, Issue.13
, pp. 1368-1373
-
-
Folsom, A.R.1
Chambless, L.E.2
Ballantyne, C.M.3
-
171
-
-
34247526815
-
Relative value of inflammatory, hemostatic, and rheological factors for incident myocardial infarction and stroke: The Edinburgh Artery Study
-
Tzoulaki I, Murray GD, Lee AJ, Rumley A, Lowe GD, Fowkes FG. Relative value of inflammatory, hemostatic, and rheological factors for incident myocardial infarction and stroke: the Edinburgh Artery Study. Circulation. 2007;115(16):2119-2127
-
(2007)
Circulation
, vol.115
, Issue.16
, pp. 2119-2127
-
-
Tzoulaki, I.1
Murray, G.D.2
Lee, A.J.3
Rumley, A.4
Lowe, G.D.5
Fowkes, F.G.6
-
172
-
-
43249118045
-
Long-term interleukin-6 levels and subsequent risk of coronary heart disease: Two new prospective studies and a systematic review
-
Danesh J, Kaptoge S, Mann AG, et al. Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review. PLoS Med. 2008;5(4):e78
-
(2008)
PLoS Med
, vol.5
, Issue.4
, pp. e78
-
-
Danesh, J.1
Kaptoge, S.2
Mann, A.G.3
-
173
-
-
67649311829
-
Soluble tumor necrosis factor receptor 1 level is associated with left ventricular hypertrophy: The northern Manhattan study
-
Takei Y, Di Tullio MR, Homma S, et al. Soluble tumor necrosis factor receptor 1 level is associated with left ventricular hypertrophy: the northern Manhattan study. Am J Hypertens. 2009;22(7):763-769
-
(2009)
Am J Hypertens
, vol.22
, Issue.7
, pp. 763-769
-
-
Takei, Y.1
Di Tullio, M.R.2
Homma, S.3
-
174
-
-
20044381106
-
Tumor necrosis factor-alpha receptor 1 is a major predictor of mortality and new-onset heart failure in patients with acute myocardial infarction: The Cytokine-Activation and Long-Term Prognosis in Myocardial Infarction (C-ALPHA) study
-
Valgimigli M, Ceconi C, Malagutti P, et al. Tumor necrosis factor-alpha receptor 1 is a major predictor of mortality and new-onset heart failure in patients with acute myocardial infarction: the Cytokine-Activation and Long-Term Prognosis in Myocardial Infarction (C-ALPHA) study. Circulation. 2005;111(7):863-870
-
(2005)
Circulation
, vol.111
, Issue.7
, pp. 863-870
-
-
Valgimigli, M.1
Ceconi, C.2
Malagutti, P.3
-
175
-
-
28244446690
-
Plasma levels of soluble tumor necrosis factor receptor type I during the acute phase following complicated myocardial infarction predicts survival in high-risk patients
-
Ueland T, Kjekshus J, Fr0land SS, et al. Plasma levels of soluble tumor necrosis factor receptor type I during the acute phase following complicated myocardial infarction predicts survival in high-risk patients. J Am Coll Cardiol. 2005;46(11):2018-2021
-
(2005)
J Am Coll Cardiol
, vol.46
, Issue.11
, pp. 2018-2021
-
-
Ueland, T.1
Kjekshus, J.2
Fr0land, S.S.3
-
176
-
-
84873535599
-
Soluble TNF receptors are associated with infarct size and ventricular dysfunction in ST-elevation myocardial infarction
-
Nilsson L, Szymanowski A, Swahn E, Jonasson L. Soluble TNF receptors are associated with infarct size and ventricular dysfunction in ST-elevation myocardial infarction. PLoS One. 2013;8(2): e55477
-
(2013)
PLoS One
, vol.8
, Issue.2
, pp. e55477
-
-
Nilsson, L.1
Szymanowski, A.2
Swahn, E.3
Jonasson, L.4
-
177
-
-
70350444860
-
The CD163-expressing macrophages recognize and internalize TWEAK: Potential consequences in atherosclerosis
-
Moreno JA, Munoz-Garcia B, Martin-Ventura JL, et al. The CD163-expressing macrophages recognize and internalize TWEAK: potential consequences in atherosclerosis. Atherosclerosis. 2009;207(1): 103-110
-
(2009)
Atherosclerosis
, vol.207
, Issue.1
, pp. 103-110
-
-
Moreno, J.A.1
Munoz-Garcia, B.2
Martin-Ventura, J.L.3
-
178
-
-
30044433255
-
The monocytic lineage specific soluble CD163 is a plasma marker of coronary atherosclerosis
-
Aristoteli LP, M0ller HJ, Bailey B, Moestrup SK, Kritharides L. The monocytic lineage specific soluble CD163 is a plasma marker of coronary atherosclerosis. Atherosclerosis. 2006;184(2):342-347
-
(2006)
Atherosclerosis
, vol.184
, Issue.2
, pp. 342-347
-
-
Aristoteli, L.P.1
M0ller, H.J.2
Bailey, B.3
Moestrup, S.K.4
Kritharides, L.5
-
179
-
-
77952889022
-
Peripheral artery disease is associated with a high CD163/TWEAK plasma ratio
-
Moreno JA, Dejouvencel T, Labreuche J, et al. Peripheral artery disease is associated with a high CD163/TWEAK plasma ratio. Arterioscler Thromb Vasc Biol. 2010;30(6):1253-1262
-
(2010)
Arterioscler Thromb Vasc Biol
, vol.30
, Issue.6
, pp. 1253-1262
-
-
Moreno, J.A.1
Dejouvencel, T.2
Labreuche, J.3
-
180
-
-
84877903534
-
Soluble CD163 does not predict first-time myocardial infarction in patients infected with human immunodeficiency virus: A nested case-control study
-
Knudsen A, M0ller HJ, Katzenstein TL, et al. Soluble CD163 does not predict first-time myocardial infarction in patients infected with human immunodeficiency virus: a nested case-control study. BMC Infect Dis. 2013;13:230
-
(2013)
BMC Infect Dis
, vol.13
, pp. 230
-
-
Knudsen, A.1
M0ller, H.J.2
Katzenstein, T.L.3
-
181
-
-
84871821878
-
Soluble CD14: Genomewide association analysis and relationship to cardiovascular risk and mortality in older adults
-
Reiner AP, Lange EM, Jenny NS, et al. Soluble CD14: genomewide association analysis and relationship to cardiovascular risk and mortality in older adults. Arterioscler Thromb Vasc Biol. 2013;33(1): 158-164
-
(2013)
Arterioscler Thromb Vasc Biol
, vol.33
, Issue.1
, pp. 158-164
-
-
Reiner, A.P.1
Lange, E.M.2
Jenny, N.S.3
-
182
-
-
84867738103
-
Biomarkers of microbial translocation and macrophage activation: Association with progression of subclinical atherosclerosis in HIV-1 infection
-
Kelesidis T, Kendall MA, Yang OO, Hodis HN, Currier JS. Biomarkers of microbial translocation and macrophage activation: association with progression of subclinical atherosclerosis in HIV-1 infection. J Infect Dis. 2012;206(10):1558-1567
-
(2012)
J Infect Dis
, vol.206
, Issue.10
, pp. 1558-1567
-
-
Kelesidis, T.1
Kendall, M.A.2
Yang, O.O.3
Hodis, H.N.4
Currier, J.S.5
-
183
-
-
78651344842
-
CD14++CD16+ monocytes and cardiovascular outcome in patients with chronic kidney disease
-
Rogacev KS, Seiler S, Zawada AM, et al. CD14++CD16+ monocytes and cardiovascular outcome in patients with chronic kidney disease. Eur Heart J. 2011;32(1):84-92
-
(2011)
Eur Heart J
, vol.32
, Issue.1
, pp. 84-92
-
-
Rogacev, K.S.1
Seiler, S.2
Zawada, A.M.3
-
184
-
-
84867404418
-
CD14++CD16+ mono-cytes independently predict cardiovascular events: A cohort study of 951 patients referred for elective coronary angiography
-
Rogacev KS, Cremers B, Zawada AM, et al. CD14++CD16+ mono-cytes independently predict cardiovascular events: a cohort study of 951 patients referred for elective coronary angiography. J Am Coll Cardiol. 2012;60(16):1512-1520
-
(2012)
J Am Coll Cardiol
, vol.60
, Issue.16
, pp. 1512-1520
-
-
Rogacev, K.S.1
Cremers, B.2
Zawada, A.M.3
-
185
-
-
39349086778
-
CD14(++)CD16+ monocytes but not total monocyte numbers predict cardiovascular events in dialysis patients
-
Heine GH, Ulrich C, Seibert E, et al. CD14(++)CD16+ monocytes but not total monocyte numbers predict cardiovascular events in dialysis patients. Kidney Int. 2008;73(5):622-629
-
(2008)
Kidney Int
, vol.73
, Issue.5
, pp. 622-629
-
-
Heine, G.H.1
Ulrich, C.2
Seibert, E.3
-
186
-
-
84920879950
-
Expression of mono-cyte subsets and angiogenic markers in relation to carotid plaque neovascularization in patients with pre-existing coronary artery disease and carotid stenosis
-
Jaipersad AS, Shantsila A, Lip GY, Shantsila E. Expression of mono-cyte subsets and angiogenic markers in relation to carotid plaque neovascularization in patients with pre-existing coronary artery disease and carotid stenosis. Ann Med. 2014;11:1-9
-
(2014)
Ann Med
, vol.11
, pp. 1-9
-
-
Jaipersad, A.S.1
Shantsila, A.2
Lip, G.Y.3
Shantsila, E.4
-
187
-
-
84860842552
-
Elevated CD14++CD16-monocytes predict cardiovascular events
-
Berg KE, Ljungcrantz I, Andersson L, et al. Elevated CD14++CD16-monocytes predict cardiovascular events. Circ Cardiovasc Genet. 2012;5(1):122-131
-
(2012)
Circ Cardiovasc Genet
, vol.5
, Issue.1
, pp. 122-131
-
-
Berg, K.E.1
Ljungcrantz, I.2
Andersson, L.3
-
188
-
-
84891612589
-
Reduced CD14 expression on classical monocytes and vascular endothelial adhesion markers independently associate with carotid artery intima media thickness in chronically HIV-1 infected adults on virologically suppressive anti-retroviral therapy
-
Barbour JD, Jalbert EC, Chow DC, et al. Reduced CD14 expression on classical monocytes and vascular endothelial adhesion markers independently associate with carotid artery intima media thickness in chronically HIV-1 infected adults on virologically suppressive anti-retroviral therapy. Atherosclerosis. 2014;232(1):52-58
-
(2014)
Atherosclerosis
, vol.232
, Issue.1
, pp. 52-58
-
-
Barbour, J.D.1
Jalbert, E.C.2
Chow, D.C.3
-
189
-
-
0031438497
-
Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: The Atherosclerosis Risk In Communities (ARIC) study
-
Hwang SJ, Ballantyne CM, Sharrett AR, et al. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. Circulation. 1997;96(12): 4219-4225
-
(1997)
Circulation
, vol.96
, Issue.12
, pp. 4219-4225
-
-
Hwang, S.J.1
Ballantyne, C.M.2
Sharrett, A.R.3
-
190
-
-
0035908941
-
Circulating cell adhesion molecules and death in patients with coronary artery disease
-
Blankenberg S, Rupprecht HJ, Bickel C, et al. Circulating cell adhesion molecules and death in patients with coronary artery disease. Circulation. 2001;104(12):1336-1342
-
(2001)
Circulation
, vol.104
, Issue.12
, pp. 1336-1342
-
-
Blankenberg, S.1
Rupprecht, H.J.2
Bickel, C.3
-
191
-
-
84894475211
-
C-reactive protein predicts 96-week carotid intima media thickness progression in HIV-infected adults naive to antiretroviral therapy
-
Hileman CO, Longenecker CT, Carman TL, McComsey GA. C-reactive protein predicts 96-week carotid intima media thickness progression in HIV-infected adults naive to antiretroviral therapy. J Acquir Immune Defic Syndr. 2014;65(3):340-344
-
(2014)
J Acquir Immune Defic Syndr
, vol.65
, Issue.3
, pp. 340-344
-
-
Hileman, C.O.1
Longenecker, C.T.2
Carman, T.L.3
McComsey, G.A.4
-
192
-
-
27744511357
-
Asymmetric dimethylargi-nine and the risk of cardiovascular events and death in patients with coronary artery disease: Results from the AtheroGene Study
-
Schnabel R, Blankenberg S, Lubos E, et al. Asymmetric dimethylargi-nine and the risk of cardiovascular events and death in patients with coronary artery disease: results from the AtheroGene Study. Circ Res. 2005;97(5):e53-e59
-
(2005)
Circ Res
, vol.97
, Issue.5
, pp. e53-e59
-
-
Schnabel, R.1
Blankenberg, S.2
Lubos, E.3
-
193
-
-
42149132162
-
Swedish-Irish-Norwegian Collaboration. Asymmetric dimethylarginine independently predicts fatal and nonfatal myocardial infarction and stroke in women: 24-year follow-up of the population study of women in Gothenburg
-
Leong T, Zylberstein D, Graham I, et al; Swedish-Irish-Norwegian Collaboration. Asymmetric dimethylarginine independently predicts fatal and nonfatal myocardial infarction and stroke in women: 24-year follow-up of the population study of women in Gothenburg. Arterioscler Thromb Vasc Biol. 2008;28(5):961-967
-
(2008)
Arterioscler Thromb Vasc Biol
, vol.28
, Issue.5
, pp. 961-967
-
-
Leong, T.1
Zylberstein, D.2
Graham, I.3
-
194
-
-
84895071402
-
Increased levels of asymmetric dimethylarginine are associated with pulmonary arterial hypertension in HIV infection
-
Parikh RV Scherzer R, Nitta EM, et al. Increased levels of asymmetric dimethylarginine are associated with pulmonary arterial hypertension in HIV infection. AIDS. 2014;28(4):511-519
-
(2014)
AIDS
, vol.28
, Issue.4
, pp. 511-519
-
-
Parikh Rv Scherzer, R.1
Nitta, E.M.2
-
195
-
-
34247132376
-
Identification of soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) as a possible biomarker of subclinical atherosclerosis
-
Blanco-Colio LM, Martin-Ventura JL, Munöz-Garcia B, et al. Identification of soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) as a possible biomarker of subclinical atherosclerosis. Arterioscler Thromb Vasc Biol. 2007;27(4):916-922
-
(2007)
Arterioscler Thromb Vasc Biol
, vol.27
, Issue.4
, pp. 916-922
-
-
Blanco-Colio, L.M.1
Martin-Ventura, J.L.2
Munöz-Garcia, B.3
-
196
-
-
69249205389
-
Circulating sTWEAK improves the prediction of coronary artery disease
-
Jelic-Ivanovic Z, Bujisic N, Spasic S, Bogavac-Stanojevic N, Spasojevic-Kalimanovska V, Kotur-Stevuljevic J. Circulating sTWEAK improves the prediction of coronary artery disease. Clin Biochem. 2009;42(13-14):1381-1386
-
(2009)
Clin Biochem
, vol.42
, Issue.13-14
, pp. 1381-1386
-
-
Jelic-Ivanovic, Z.1
Bujisic, N.2
Spasic, S.3
Bogavac-Stanojevic, N.4
Spasojevic-Kalimanovska, V.5
Kotur-Stevuljevic, J.6
-
197
-
-
79955566226
-
Soluble TWEAK and PTX3 in nondialysis CKD patients: Impact on endothelial dysfunction and cardiovascular outcomes
-
Yilmaz MI, Sonmez A, Ortiz A, et al. Soluble TWEAK and PTX3 in nondialysis CKD patients: impact on endothelial dysfunction and cardiovascular outcomes. Clin J Am Soc Nephrol. 2011;6(4):785-792
-
(2011)
Clin J Am Soc Nephrol
, vol.6
, Issue.4
, pp. 785-792
-
-
Yilmaz, M.I.1
Sonmez, A.2
Ortiz, A.3
-
198
-
-
70350673929
-
levels predict an adverse prognosis in patients with chronic stable heart failure
-
Chorianopoulos E, Rosenberg M, Zugck C, Wolf J, Katus HA, Frey N. Decreased soluble TWEAK levels predict an adverse prognosis in patients with chronic stable heart failure. Eur J Heart Fail. 2009;11(11):1050-1056
-
(2009)
Eur J Heart Fail
, vol.11
, Issue.11
, pp. 1050-1056
-
-
Chorianopoulos, E.1
Rosenberg, M.2
Zugck, C.3
Wolf, J.4
Katus, H.A.5
Frey, N.6
Decreased Soluble, T.W.E.A.K.7
-
199
-
-
82955167882
-
Impact of soluble TWEAK and CD163/TWEAK ratio on long-term cardiovascular mortality in patients with peripheral arterial disease
-
Urbonaviciene G, Martin-Ventura JL, Lindholt JS, et al. Impact of soluble TWEAK and CD163/TWEAK ratio on long-term cardiovascular mortality in patients with peripheral arterial disease. Atherosclerosis. 2011;219(2):892-899
-
(2011)
Atherosclerosis
, vol.219
, Issue.2
, pp. 892-899
-
-
Urbonaviciene, G.1
Martin-Ventura, J.L.2
Lindholt, J.S.3
|